JP2009519235A - Dentifrice composition comprising a binder system comprising a hydrophilic clay material - Google Patents
Dentifrice composition comprising a binder system comprising a hydrophilic clay material Download PDFInfo
- Publication number
- JP2009519235A JP2009519235A JP2008542918A JP2008542918A JP2009519235A JP 2009519235 A JP2009519235 A JP 2009519235A JP 2008542918 A JP2008542918 A JP 2008542918A JP 2008542918 A JP2008542918 A JP 2008542918A JP 2009519235 A JP2009519235 A JP 2009519235A
- Authority
- JP
- Japan
- Prior art keywords
- zinc
- dentifrice composition
- composition
- oral care
- mixtures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 138
- 239000000463 material Substances 0.000 title claims abstract description 51
- 239000000551 dentifrice Substances 0.000 title claims abstract description 35
- 239000011230 binding agent Substances 0.000 title claims abstract description 23
- 239000004927 clay Substances 0.000 title claims abstract description 17
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 16
- 229920000642 polymer Polymers 0.000 claims abstract description 13
- 239000002798 polar solvent Substances 0.000 claims abstract description 12
- 229920006318 anionic polymer Polymers 0.000 claims abstract description 10
- 229920002678 cellulose Polymers 0.000 claims abstract description 10
- 239000001913 cellulose Substances 0.000 claims abstract description 10
- 244000043261 Hevea brasiliensis Species 0.000 claims abstract description 9
- 229920003052 natural elastomer Polymers 0.000 claims abstract description 9
- 229920001194 natural rubber Polymers 0.000 claims abstract description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 38
- 239000011701 zinc Substances 0.000 claims description 36
- 229910052725 zinc Inorganic materials 0.000 claims description 36
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 30
- 150000003839 salts Chemical class 0.000 claims description 26
- -1 phytic acid compound Chemical class 0.000 claims description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 21
- 230000000694 effects Effects 0.000 claims description 20
- 239000003082 abrasive agent Substances 0.000 claims description 17
- 235000002949 phytic acid Nutrition 0.000 claims description 14
- 239000000377 silicon dioxide Substances 0.000 claims description 14
- 229910001432 tin ion Inorganic materials 0.000 claims description 13
- 239000013543 active substance Substances 0.000 claims description 12
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 11
- 230000002087 whitening effect Effects 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 230000002272 anti-calculus Effects 0.000 claims description 9
- 230000002882 anti-plaque Effects 0.000 claims description 8
- 239000003963 antioxidant agent Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 229940068041 phytic acid Drugs 0.000 claims description 8
- 239000000467 phytic acid Substances 0.000 claims description 8
- 229920000388 Polyphosphate Polymers 0.000 claims description 7
- 239000001205 polyphosphate Substances 0.000 claims description 7
- 235000011176 polyphosphates Nutrition 0.000 claims description 7
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 6
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 235000015097 nutrients Nutrition 0.000 claims description 5
- UOURRHZRLGCVDA-UHFFFAOYSA-D pentazinc;dicarbonate;hexahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Zn+2].[Zn+2].[Zn+2].[Zn+2].[Zn+2].[O-]C([O-])=O.[O-]C([O-])=O UOURRHZRLGCVDA-UHFFFAOYSA-D 0.000 claims description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 4
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 4
- 239000010949 copper Substances 0.000 claims description 4
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 3
- 229940005553 analgesics and anesthetics Drugs 0.000 claims description 3
- 235000011180 diphosphates Nutrition 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 239000000391 magnesium silicate Substances 0.000 claims description 3
- 229910052919 magnesium silicate Inorganic materials 0.000 claims description 3
- 235000019792 magnesium silicate Nutrition 0.000 claims description 3
- 229910052604 silicate mineral Inorganic materials 0.000 claims description 3
- 229960003500 triclosan Drugs 0.000 claims description 3
- MQWLIFWNJWLDCI-UHFFFAOYSA-L zinc;carbonate;hydrate Chemical compound O.[Zn+2].[O-]C([O-])=O MQWLIFWNJWLDCI-UHFFFAOYSA-L 0.000 claims description 3
- 241000692870 Inachis io Species 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 2
- 229910052615 phyllosilicate Inorganic materials 0.000 claims description 2
- 239000004575 stone Substances 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 230000001680 brushing effect Effects 0.000 claims 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims 1
- SUCKQWWOYOOODR-UHFFFAOYSA-K copper;zinc;carbonate;hydroxide Chemical compound [OH-].[Cu+2].[Zn+2].[O-]C([O-])=O SUCKQWWOYOOODR-UHFFFAOYSA-K 0.000 claims 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 description 24
- 239000000047 product Substances 0.000 description 16
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 15
- 230000008901 benefit Effects 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000008375 oral care agent Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 10
- 229910052783 alkali metal Inorganic materials 0.000 description 10
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000000975 dye Substances 0.000 description 8
- 229910052751 metal Inorganic materials 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- 235000010755 mineral Nutrition 0.000 description 8
- 239000011707 mineral Substances 0.000 description 8
- 239000000049 pigment Substances 0.000 description 8
- 239000011667 zinc carbonate Substances 0.000 description 8
- 235000004416 zinc carbonate Nutrition 0.000 description 8
- 229910000010 zinc carbonate Inorganic materials 0.000 description 8
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 229920000098 polyolefin Polymers 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 239000000600 sorbitol Substances 0.000 description 6
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 239000000606 toothpaste Substances 0.000 description 6
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 5
- 230000000675 anti-caries Effects 0.000 description 5
- 239000003443 antiviral agent Substances 0.000 description 5
- 229920001525 carrageenan Polymers 0.000 description 5
- NFCRBQADEGXVDL-UHFFFAOYSA-M cetylpyridinium chloride monohydrate Chemical compound O.[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NFCRBQADEGXVDL-UHFFFAOYSA-M 0.000 description 5
- 239000013256 coordination polymer Substances 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 229940008099 dimethicone Drugs 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 239000011775 sodium fluoride Substances 0.000 description 5
- 235000013024 sodium fluoride Nutrition 0.000 description 5
- 229960002799 stannous fluoride Drugs 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 150000001340 alkali metals Chemical class 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 235000010418 carrageenan Nutrition 0.000 description 4
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical class OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 238000011065 in-situ storage Methods 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000000518 rheometry Methods 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical class [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 4
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- ORZHVTYKPFFVMG-UHFFFAOYSA-N xylenol orange Chemical compound OC(=O)CN(CC(O)=O)CC1=C(O)C(C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(CN(CC(O)=O)CC(O)=O)C(O)=C(C)C=2)=C1 ORZHVTYKPFFVMG-UHFFFAOYSA-N 0.000 description 4
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 208000006558 Dental Calculus Diseases 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 229920002148 Gellan gum Polymers 0.000 description 3
- 241000871495 Heeria argentea Species 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 150000001336 alkenes Chemical group 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 229920001222 biopolymer Polymers 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000007859 condensation product Substances 0.000 description 3
- 210000003298 dental enamel Anatomy 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 150000004673 fluoride salts Chemical class 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 208000007565 gingivitis Diseases 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical class [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- 229940083982 sodium phytate Drugs 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 229940034610 toothpaste Drugs 0.000 description 3
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- GPXCJKUXBIGASD-UHFFFAOYSA-N 1-phosphonobutane-1,2,4-tricarboxylic acid Chemical compound OC(=O)CCC(C(O)=O)C(C(O)=O)P(O)(O)=O GPXCJKUXBIGASD-UHFFFAOYSA-N 0.000 description 2
- YFVBASFBIJFBAI-UHFFFAOYSA-M 1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=CC=C1 YFVBASFBIJFBAI-UHFFFAOYSA-M 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- FHEHIXJLCWUPCZ-UHFFFAOYSA-N 4-prop-2-enylbenzene-1,2-diol Chemical compound OC1=CC=C(CC=C)C=C1O FHEHIXJLCWUPCZ-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical group [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 229920002556 Polyethylene Glycol 300 Polymers 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- IWEDUKDKQUXPLH-NFJZTGFVSA-L [Mg++].OP(O)(=O)O[C@H]1[C@@H](OP(O)(O)=O)C(OP(O)([O-])=O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)C1OP(O)([O-])=O Chemical compound [Mg++].OP(O)(=O)O[C@H]1[C@@H](OP(O)(O)=O)C(OP(O)([O-])=O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)C1OP(O)([O-])=O IWEDUKDKQUXPLH-NFJZTGFVSA-L 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 229910001515 alkali metal fluoride Inorganic materials 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003610 anti-gingivitis Effects 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 2
- 235000019402 calcium peroxide Nutrition 0.000 description 2
- 229940078916 carbamide peroxide Drugs 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 2
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 2
- JJLJMEJHUUYSSY-UHFFFAOYSA-L copper(II) hydroxide Inorganic materials [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 2
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 229940091249 fluoride supplement Drugs 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229910021485 fumed silica Inorganic materials 0.000 description 2
- 235000010492 gellan gum Nutrition 0.000 description 2
- 239000000216 gellan gum Substances 0.000 description 2
- WPEXVRDUEAJUGY-UHFFFAOYSA-B hexacalcium;(2,3,4,5,6-pentaphosphonatooxycyclohexyl) phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])(=O)OC1C(OP([O-])([O-])=O)C(OP([O-])([O-])=O)C(OP([O-])([O-])=O)C(OP([O-])([O-])=O)C1OP([O-])([O-])=O WPEXVRDUEAJUGY-UHFFFAOYSA-B 0.000 description 2
- 229940005740 hexametaphosphate Drugs 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 2
- 229960004752 ketorolac Drugs 0.000 description 2
- 229940094522 laponite Drugs 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 210000003300 oropharynx Anatomy 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 2
- CPJSUEIXXCENMM-UHFFFAOYSA-N phenacetin Chemical compound CCOC1=CC=C(NC(C)=O)C=C1 CPJSUEIXXCENMM-UHFFFAOYSA-N 0.000 description 2
- ZJAOAACCNHFJAH-UHFFFAOYSA-N phosphonoformic acid Chemical compound OC(=O)P(O)(O)=O ZJAOAACCNHFJAH-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- JTDPJYXDDYUJBS-UHFFFAOYSA-N quinoline-2-carbohydrazide Chemical compound C1=CC=CC2=NC(C(=O)NN)=CC=C21 JTDPJYXDDYUJBS-UHFFFAOYSA-N 0.000 description 2
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 2
- 229960002218 sodium chlorite Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 150000003871 sulfonates Chemical class 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
- JTDNNCYXCFHBGG-UHFFFAOYSA-L tin(ii) iodide Chemical compound I[Sn]I JTDNNCYXCFHBGG-UHFFFAOYSA-L 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 235000019801 trisodium phosphate Nutrition 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- GDRWQOJIKFWLOC-UHFFFAOYSA-N (2-phosphonopyrrolidin-2-yl)phosphonic acid Chemical compound OP(O)(=O)C1(P(O)(O)=O)CCCN1 GDRWQOJIKFWLOC-UHFFFAOYSA-N 0.000 description 1
- YXTDAZMTQFUZHK-ZVGUSBNCSA-L (2r,3r)-2,3-dihydroxybutanedioate;tin(2+) Chemical compound [Sn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O YXTDAZMTQFUZHK-ZVGUSBNCSA-L 0.000 description 1
- CKUJRAYMVVJDMG-IYEMJOQQSA-L (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;tin(2+) Chemical compound [Sn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O CKUJRAYMVVJDMG-IYEMJOQQSA-L 0.000 description 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
- WRRSFOZOETZUPG-FFHNEAJVSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;hydrate Chemical compound O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC WRRSFOZOETZUPG-FFHNEAJVSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- JLPAMKUIIFHLBH-UHFFFAOYSA-N 1,2-dihydroxypropane-1-sulfonic acid Chemical compound CC(O)C(O)S(O)(=O)=O JLPAMKUIIFHLBH-UHFFFAOYSA-N 0.000 description 1
- OQBLGYCUQGDOOR-UHFFFAOYSA-L 1,3,2$l^{2}-dioxastannolane-4,5-dione Chemical compound O=C1O[Sn]OC1=O OQBLGYCUQGDOOR-UHFFFAOYSA-L 0.000 description 1
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- RNHWYOLIEJIAMV-UHFFFAOYSA-N 1-chlorotetradecane Chemical compound CCCCCCCCCCCCCCCl RNHWYOLIEJIAMV-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- IHWDSEPNZDYMNF-UHFFFAOYSA-N 1H-indol-2-amine Chemical class C1=CC=C2NC(N)=CC2=C1 IHWDSEPNZDYMNF-UHFFFAOYSA-N 0.000 description 1
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 description 1
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- RWMSXNCJNSILON-UHFFFAOYSA-N 2-[4-(2-propylpentyl)piperidin-1-yl]ethanol Chemical compound CCCC(CCC)CC1CCN(CCO)CC1 RWMSXNCJNSILON-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- UDFNOXIWFOPREQ-UHFFFAOYSA-N 2-phosphonopropane-1,1,1-tricarboxylic acid Chemical compound OP(=O)(O)C(C)C(C(O)=O)(C(O)=O)C(O)=O UDFNOXIWFOPREQ-UHFFFAOYSA-N 0.000 description 1
- MEJYDZQQVZJMPP-UHFFFAOYSA-N 3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound COC1COC2C(OC)COC21 MEJYDZQQVZJMPP-UHFFFAOYSA-N 0.000 description 1
- USYAMXSCYLGBPT-UHFFFAOYSA-L 3-carboxy-3-hydroxypentanedioate;tin(2+) Chemical compound [Sn+2].OC(=O)CC(O)(C([O-])=O)CC([O-])=O USYAMXSCYLGBPT-UHFFFAOYSA-L 0.000 description 1
- PJJGZPJJTHBVMX-UHFFFAOYSA-N 5,7-Dihydroxyisoflavone Chemical compound C=1C(O)=CC(O)=C(C2=O)C=1OC=C2C1=CC=CC=C1 PJJGZPJJTHBVMX-UHFFFAOYSA-N 0.000 description 1
- FEEPYEXHXJWMAX-UHFFFAOYSA-N 6-benzyl-2,6-diazaspiro[3.4]octane Chemical compound C=1C=CC=CC=1CN(C1)CCC21CNC2 FEEPYEXHXJWMAX-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 239000004155 Chlorine dioxide Substances 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- VWFCHDSQECPREK-LURJTMIESA-N Cidofovir Chemical compound NC=1C=CN(C[C@@H](CO)OCP(O)(O)=O)C(=O)N=1 VWFCHDSQECPREK-LURJTMIESA-N 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229910021594 Copper(II) fluoride Inorganic materials 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical class O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 244000062241 Kaempferia galanga Species 0.000 description 1
- 235000013421 Kaempferia galanga Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- SBDNJUWAMKYJOX-UHFFFAOYSA-N Meclofenamic Acid Chemical compound CC1=CC=C(Cl)C(NC=2C(=CC=CC=2)C(O)=O)=C1Cl SBDNJUWAMKYJOX-UHFFFAOYSA-N 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- UQCNKQCJZOAFTQ-ISWURRPUSA-N Oxymorphone Chemical compound O([C@H]1C(CC[C@]23O)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O UQCNKQCJZOAFTQ-ISWURRPUSA-N 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229910052774 Proactinium Inorganic materials 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- OZBDFBJXRJWNAV-UHFFFAOYSA-N Rimantadine hydrochloride Chemical compound Cl.C1C(C2)CC3CC2CC1(C(N)C)C3 OZBDFBJXRJWNAV-UHFFFAOYSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241000651385 Scutaria Species 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 206010041857 Squamous cell carcinoma of the oral cavity Diseases 0.000 description 1
- 208000035518 Squamous cell carcinoma of the oropharynx Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 108010036928 Thiorphan Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 229920002709 Ultraz Polymers 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- HDOVUKNUBWVHOX-QMMMGPOBSA-N Valacyclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCOC(=O)[C@@H](N)C(C)C)C=N2 HDOVUKNUBWVHOX-QMMMGPOBSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- WOHVONCNVLIHKY-UHFFFAOYSA-L [Ba+2].[O-]Cl=O.[O-]Cl=O Chemical compound [Ba+2].[O-]Cl=O.[O-]Cl=O WOHVONCNVLIHKY-UHFFFAOYSA-L 0.000 description 1
- VQOUUMIHPIODKC-UHFFFAOYSA-K [O-]C(C1=CC=CC=C1C([O-])=O)=O.[O-]C(C1=CC=CC=C1C(O)=O)=O.[Mg+2].[K+] Chemical compound [O-]C(C1=CC=CC=C1C([O-])=O)=O.[O-]C(C1=CC=CC=C1C(O)=O)=O.[Mg+2].[K+] VQOUUMIHPIODKC-UHFFFAOYSA-K 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960001413 acetanilide Drugs 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000001243 acetic acids Chemical class 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000004974 alkaline earth metal peroxides Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940111133 antiinflammatory and antirheumatic drug oxicams Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000004287 bisbiguanides Chemical class 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 1
- 229960001736 buprenorphine Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- QXIKMJLSPJFYOI-UHFFFAOYSA-L calcium;dichlorite Chemical compound [Ca+2].[O-]Cl=O.[O-]Cl=O QXIKMJLSPJFYOI-UHFFFAOYSA-L 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000019398 chlorine dioxide Nutrition 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052619 chlorite group Inorganic materials 0.000 description 1
- 229940077239 chlorous acid Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 229960000724 cidofovir Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- HJKBJIYDJLVSAO-UHFFFAOYSA-L clodronic acid disodium salt Chemical compound [Na+].[Na+].OP([O-])(=O)C(Cl)(Cl)P(O)([O-])=O HJKBJIYDJLVSAO-UHFFFAOYSA-L 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Natural products C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- SOYFYCJCFAHQDV-UHFFFAOYSA-J copper zinc dicarbonate Chemical compound [Cu++].[Zn++].[O-]C([O-])=O.[O-]C([O-])=O SOYFYCJCFAHQDV-UHFFFAOYSA-J 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 1
- GWFAVIIMQDUCRA-UHFFFAOYSA-L copper(ii) fluoride Chemical compound [F-].[F-].[Cu+2] GWFAVIIMQDUCRA-UHFFFAOYSA-L 0.000 description 1
- AEJIMXVJZFYIHN-UHFFFAOYSA-N copper;dihydrate Chemical compound O.O.[Cu] AEJIMXVJZFYIHN-UHFFFAOYSA-N 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- QSFOWAYMMZCQNF-UHFFFAOYSA-N delmopinol Chemical compound CCCC(CCC)CCCC1COCCN1CCO QSFOWAYMMZCQNF-UHFFFAOYSA-N 0.000 description 1
- 229960003854 delmopinol Drugs 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- PNOXNTGLSKTMQO-UHFFFAOYSA-L diacetyloxytin Chemical compound CC(=O)O[Sn]OC(C)=O PNOXNTGLSKTMQO-UHFFFAOYSA-L 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- HUPFGZXOMWLGNK-UHFFFAOYSA-N diflunisal Chemical compound C1=C(O)C(C(=O)O)=CC(C=2C(=CC(F)=CC=2)F)=C1 HUPFGZXOMWLGNK-UHFFFAOYSA-N 0.000 description 1
- 229960000616 diflunisal Drugs 0.000 description 1
- XQRLCLUYWUNEEH-UHFFFAOYSA-N diphosphonic acid Chemical class OP(=O)OP(O)=O XQRLCLUYWUNEEH-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- CQAIPTBBCVQRMD-UHFFFAOYSA-L dipotassium;phosphono phosphate Chemical compound [K+].[K+].OP(O)(=O)OP([O-])([O-])=O CQAIPTBBCVQRMD-UHFFFAOYSA-L 0.000 description 1
- 229940042396 direct acting antivirals thiosemicarbazones Drugs 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical group [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229960005293 etodolac Drugs 0.000 description 1
- XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960004396 famciclovir Drugs 0.000 description 1
- GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 229940083282 fd&c blue #2 lake Drugs 0.000 description 1
- 229960001419 fenoprofen Drugs 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- IVLVTNPOHDFFCJ-UHFFFAOYSA-N fentanyl citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 IVLVTNPOHDFFCJ-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 229960005102 foscarnet Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002963 ganciclovir Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- HNMCSUXJLGGQFO-UHFFFAOYSA-N hexaaluminum;hexasodium;tetrathietane;hexasilicate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].S1SSS1.S1SSS1.[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] HNMCSUXJLGGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960004867 hexetidine Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- DLINORNFHVEIFE-UHFFFAOYSA-N hydrogen peroxide;zinc Chemical compound [Zn].OO DLINORNFHVEIFE-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960004716 idoxuridine Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910001506 inorganic fluoride Inorganic materials 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960002358 iodine Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229960001518 levocarnitine Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- KAGBQTDQNWOCND-UHFFFAOYSA-M lithium;chlorite Chemical compound [Li+].[O-]Cl=O KAGBQTDQNWOCND-UHFFFAOYSA-M 0.000 description 1
- 229960004995 magnesium peroxide Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- NWAPVVCSZCCZCU-UHFFFAOYSA-L magnesium;dichlorite Chemical compound [Mg+2].[O-]Cl=O.[O-]Cl=O NWAPVVCSZCCZCU-UHFFFAOYSA-L 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- FQXXSQDCDRQNQE-UHFFFAOYSA-N markiertes Thebain Natural products COC1=CC=C2C(N(CC3)C)CC4=CC=C(OC)C5=C4C23C1O5 FQXXSQDCDRQNQE-UHFFFAOYSA-N 0.000 description 1
- 229960003803 meclofenamic acid Drugs 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical class COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229960004270 nabumetone Drugs 0.000 description 1
- NETZHAKZCGBWSS-CEDHKZHLSA-N nalbuphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]1(O)CC[C@@H]3O)CN2CC1CCC1 NETZHAKZCGBWSS-CEDHKZHLSA-N 0.000 description 1
- 229960000805 nalbuphine Drugs 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 229950002404 octapinol Drugs 0.000 description 1
- 229960001774 octenidine Drugs 0.000 description 1
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 208000010655 oral cavity squamous cell carcinoma Diseases 0.000 description 1
- PGZUMBJQJWIWGJ-ONAKXNSWSA-N oseltamivir phosphate Chemical compound OP(O)(O)=O.CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 PGZUMBJQJWIWGJ-ONAKXNSWSA-N 0.000 description 1
- 229960002194 oseltamivir phosphate Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229960005118 oxymorphone Drugs 0.000 description 1
- 229960000649 oxyphenbutazone Drugs 0.000 description 1
- CNDQSXOVEQXJOE-UHFFFAOYSA-N oxyphenbutazone hydrate Chemical compound O.O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 CNDQSXOVEQXJOE-UHFFFAOYSA-N 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- VOKSWYLNZZRQPF-GDIGMMSISA-N pentazocine Chemical compound C1C2=CC=C(O)C=C2[C@@]2(C)[C@@H](C)[C@@H]1N(CC=C(C)C)CC2 VOKSWYLNZZRQPF-GDIGMMSISA-N 0.000 description 1
- 229960005301 pentazocine Drugs 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 125000005342 perphosphate group Chemical group 0.000 description 1
- 229960003893 phenacetin Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- VISKNDGJUCDNMS-UHFFFAOYSA-M potassium;chlorite Chemical compound [K+].[O-]Cl=O VISKNDGJUCDNMS-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000009516 primary packaging Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- COALSIYJQHMCDX-UHFFFAOYSA-L propanedioate;tin(2+) Chemical compound [Sn+2].[O-]C(=O)CC([O-])=O COALSIYJQHMCDX-UHFFFAOYSA-L 0.000 description 1
- 150000004672 propanoic acids Chemical class 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960000888 rimantadine Drugs 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 description 1
- 229950000975 salicylanilide Drugs 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 229940084560 sanguinarine Drugs 0.000 description 1
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- BBMHARZCALWXSL-UHFFFAOYSA-M sodium dihydrogenphosphate monohydrate Chemical compound O.[Na+].OP(O)([O-])=O BBMHARZCALWXSL-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 229940045872 sodium percarbonate Drugs 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- 229940050865 sodium phosphate,monobasic,monohydrate Drugs 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- ILJOYZVVZZFIKA-UHFFFAOYSA-M sodium;1,1-dioxo-1,2-benzothiazol-3-olate;hydrate Chemical compound O.[Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 ILJOYZVVZZFIKA-UHFFFAOYSA-M 0.000 description 1
- JJICLMJFIKGAAU-UHFFFAOYSA-M sodium;2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)purin-6-olate Chemical compound [Na+].NC1=NC([O-])=C2N=CN(COC(CO)CO)C2=N1 JJICLMJFIKGAAU-UHFFFAOYSA-M 0.000 description 1
- RMLUKZWYIKEASN-UHFFFAOYSA-M sodium;2-amino-9-(2-hydroxyethoxymethyl)purin-6-olate Chemical compound [Na+].O=C1[N-]C(N)=NC2=C1N=CN2COCCO RMLUKZWYIKEASN-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- NYKCGQQJNVPOLU-ONTIZHBOSA-N spiradoline Chemical compound C([C@@H]([C@H](C1)N2CCCC2)N(C)C(=O)CC=2C=C(Cl)C(Cl)=CC=2)C[C@]21CCCO2 NYKCGQQJNVPOLU-ONTIZHBOSA-N 0.000 description 1
- 229950006495 spiradoline Drugs 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 229940108184 stannous iodide Drugs 0.000 description 1
- RCIVOBGSMSSVTR-UHFFFAOYSA-L stannous sulfate Chemical compound [SnH2+2].[O-]S([O-])(=O)=O RCIVOBGSMSSVTR-UHFFFAOYSA-L 0.000 description 1
- 229940007163 stannous tartrate Drugs 0.000 description 1
- 239000002294 steroidal antiinflammatory agent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- UHCGLDSRFKGERO-UHFFFAOYSA-N strontium peroxide Chemical compound [Sr+2].[O-][O-] UHCGLDSRFKGERO-UHFFFAOYSA-N 0.000 description 1
- 159000000008 strontium salts Chemical class 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- AGGIJOLULBJGTQ-UHFFFAOYSA-N sulfoacetic acid Chemical class OC(=O)CS(O)(=O)=O AGGIJOLULBJGTQ-UHFFFAOYSA-N 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 1
- 229960000894 sulindac Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 229930003945 thebaine Natural products 0.000 description 1
- FQXXSQDCDRQNQE-VMDGZTHMSA-N thebaine Chemical compound C([C@@H](N(CC1)C)C2=CC=C3OC)C4=CC=C(OC)C5=C4[C@@]21[C@H]3O5 FQXXSQDCDRQNQE-VMDGZTHMSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- LJJKNPQAGWVLDQ-SNVBAGLBSA-N thiorphan Chemical compound OC(=O)CNC(=O)[C@@H](CS)CC1=CC=CC=C1 LJJKNPQAGWVLDQ-SNVBAGLBSA-N 0.000 description 1
- 150000003584 thiosemicarbazones Chemical class 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 229910000375 tin(II) sulfate Inorganic materials 0.000 description 1
- UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 1
- 229960001017 tolmetin Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940001496 tribasic sodium phosphate Drugs 0.000 description 1
- 229960003962 trifluridine Drugs 0.000 description 1
- VSQQQLOSPVPRAZ-RRKCRQDMSA-N trifluridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(C(F)(F)F)=C1 VSQQQLOSPVPRAZ-RRKCRQDMSA-N 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- MLIKYFGFHUYZAL-UHFFFAOYSA-K trisodium;hydron;phosphonato phosphate Chemical group [Na+].[Na+].[Na+].OP([O-])(=O)OP([O-])([O-])=O MLIKYFGFHUYZAL-UHFFFAOYSA-K 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- VSJRDSLPNMGNFG-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate;trihydrate Chemical compound O.O.O.[Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O VSJRDSLPNMGNFG-UHFFFAOYSA-H 0.000 description 1
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 1
- 229940030300 trolamine salicylate Drugs 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229940093257 valacyclovir Drugs 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- ARAIBEBZBOPLMB-UFGQHTETSA-N zanamivir Chemical compound CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO ARAIBEBZBOPLMB-UFGQHTETSA-N 0.000 description 1
- 229960001028 zanamivir Drugs 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 229940085658 zinc citrate trihydrate Drugs 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 229940105296 zinc peroxide Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- VOSQOLXQDQZVCL-UHFFFAOYSA-L zinc;chloride;hydroxide Chemical compound [OH-].[Cl-].[Zn+2] VOSQOLXQDQZVCL-UHFFFAOYSA-L 0.000 description 1
- PCHQDTOLHOFHHK-UHFFFAOYSA-L zinc;hydrogen carbonate Chemical compound [Zn+2].OC([O-])=O.OC([O-])=O PCHQDTOLHOFHHK-UHFFFAOYSA-L 0.000 description 1
- QAOTYOGEQAZIFQ-UHFFFAOYSA-M zinc;hydroxide;nitrate Chemical compound [OH-].[Zn+2].[O-][N+]([O-])=O QAOTYOGEQAZIFQ-UHFFFAOYSA-M 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8135—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid; Compositions of derivatives of such polymers, e.g. vinyl esters (polyvinylacetate)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
- A61K2800/5424—Polymers characterized by specific structures/properties characterized by the charge anionic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
約10,000Pa〜約450,000Paの粘度を有する歯磨剤組成物は、(a)親水性粘土材、変性セルロースポリマー、カルボキシビニルポリマー及びアニオン性ポリマー由来の天然ゴム類を含む結合剤系と、b)口腔ケア活性物質の有効量と、(c)極性溶媒キャリアとを備える。 A dentifrice composition having a viscosity of from about 10,000 Pa to about 450,000 Pa comprises: (a) a binder system comprising natural rubbers derived from a hydrophilic clay material, a modified cellulose polymer, a carboxyvinyl polymer and an anionic polymer; b) comprising an effective amount of an oral care active and (c) a polar solvent carrier.
Description
本発明は、親水性粘土材を含む結合剤系を備える歯磨剤組成物に関し、広範囲の処方に高い安定性を提供する。 The present invention relates to a dentifrice composition comprising a binder system comprising a hydrophilic clay material and provides high stability for a wide range of formulations.
練り歯磨き等の歯磨剤組成物は、口腔ケア衛生レジメンの一部として消費者により日常的に使用される。口腔ケア製品が消費者に、治療上及び美容上両方の健康法の利益を提供できることは周知である。治療上の利益としては、虫歯防止、歯肉炎防止及び過敏症調節が挙げられるが、これらに限定されない。美容上の利益としては、歯垢及び歯石処方の調節、歯汚れの除去及び防止、歯の白化、呼吸フレッシュニング並びに爽やかな感覚又はつるつるした感覚の感触等の口感触の審美性が挙げられるがこれらに限定されない。 Dentifrice compositions such as toothpastes are routinely used by consumers as part of an oral care hygiene regimen. It is well known that oral care products can provide consumers with both therapeutic and cosmetic health benefits. Therapeutic benefits include, but are not limited to, caries prevention, gingivitis prevention and hypersensitivity modulation. Cosmetic benefits include adjustment of plaque and tartar prescriptions, removal and prevention of tooth stains, tooth whitening, respiratory freshening and mouthfeel aesthetics such as fresh or slippery sensations. It is not limited to these.
シリカ等の研磨材の使用は長い間、歯磨剤組成物の上記治療上及び美容上の利益を提供するために重要と考えられていた。研磨材は、歯ブラシと歯の間に物理的な磨耗を加えて歯垢、染み及び歯石を洗浄し、同時に全体的な処方の熱安定性を保持するため歯磨剤のレオロジー及び構造も構築する。 The use of abrasives such as silica has long been considered important to provide the above therapeutic and cosmetic benefits of dentifrice compositions. Abrasives add physical wear between the toothbrush and teeth to clean plaque, stains and tartar, while at the same time building the rheology and structure of the dentifrice to maintain the thermal stability of the overall formulation.
しかし、同時に高レベルでの研磨材の使用は、全般的な処方にネガティブな影響を有する場合もある。例えば、シリカ自体の原価は、高価である。更に、シリカは、活性物質剤類、フレーバ類及び発泡剤類等の典型的な歯磨剤組成物の構成成分を吸着する、そのため、これらの構成成分の濃度は、シリカによる損失を見越して調製されなければならない。更に、塩化セチルピリジニウム等のある活性物質剤類は、シリカとの相溶性が劣る、従って、その周知の効果にもかかわらず歯磨剤組成物に含めることができない。別の態様において、歯を余りにも強く磨くと、研磨材がエナメル質を侵蝕する場合があるというのが一般消費者の概念である。 At the same time, however, the use of high levels of abrasives can have a negative impact on the overall formulation. For example, the cost of silica itself is expensive. Furthermore, silica adsorbs the components of typical dentifrice compositions such as active agent agents, flavors and foaming agents, so the concentration of these components is adjusted to allow for loss due to silica. There must be. Furthermore, certain active agent agents such as cetylpyridinium chloride are poorly compatible with silica and therefore cannot be included in dentifrice compositions despite their well-known effects. In another aspect, the general consumer concept is that if the teeth are brushed too hard, the abrasive may attack the enamel.
上記に基づき、研磨剤の少ない又は有しない、今までどおり通常の歯磨剤組成物の利益を提供できる歯磨剤組成物が必要である。具体的には、広範囲の処方にわたって熱的に安定で、同じ洗浄利益を市場に提供できる歯磨剤組成物が必要である。 Based on the above, there is a need for a dentifrice composition that can still provide the benefits of conventional dentifrice compositions with little or no abrasive. Specifically, there is a need for a dentifrice composition that is thermally stable over a wide range of formulations and can provide the same cleaning benefits to the market.
本発明は、
(a)
i)親水性粘土材、
ii)変性セルロースポリマー、
iii)カルボキシビニルポリマー及びiv)アニオン性ポリマー由来の天然ゴム類を含む約10,000Pa〜約450,000Paの粘度を有する結合剤系と、
(b)口腔ケア活性物質の有効量と、
(c)極性溶媒キャリアとを備える歯磨剤組成物を目的とする。
The present invention
(A)
i) hydrophilic clay material,
ii) modified cellulose polymer,
a binder system having a viscosity of from about 10,000 Pa to about 450,000 Pa comprising iii) carboxyvinyl polymer and iv) natural rubbers derived from anionic polymers;
(B) an effective amount of an oral care active substance;
(C) A dentifrice composition comprising a polar solvent carrier.
本発明は、更に研磨剤のない歯を洗浄する方法を目的とする。 The present invention is further directed to a method of cleaning teeth without an abrasive.
添付の特許請求の範囲と共に本明細書の開示内容を読むことによって、本発明におけるこれら並びにその他の特徴、態様、及び利点が当業者に明らかになる。 These and other features, aspects and advantages of the present invention will become apparent to those skilled in the art upon reading the disclosure herein together with the appended claims.
次のリストは本明細書において使用する用語の定義である。 The following list is a definition of terms used herein.
「含む」とは、最終結果に影響を及ぼさない他の工程及び他の成分を加えることができることを意味する。この用語には、「から成る」及び「から本質的に成る」という用語が包含される。 “Including” means that other steps and other components that do not affect the final result can be added. This term encompasses the terms “consisting of” and “consisting essentially of”.
特に記述されない限り、全ての百分率は、組成物全体の重量によるものである。 Unless otherwise stated, all percentages are by weight of the entire composition.
引用した参照文献はすべて、それらの全体が本明細書に参考として組み込まれる。いかなる参照文献の引用も、特許請求した発明の従来技術としての有用性についての限定に関する容認ではない。 All cited references are incorporated herein by reference in their entirety. Citation of any reference is not an admission regarding a limitation on the usefulness of the claimed invention as prior art.
特に記載のない限り、全ての比率は重量比である。 Unless otherwise stated, all ratios are weight ratios.
本発明をその生成物及びプロセス態様に関して、次のように詳細に記載する。 The present invention is described in detail as follows with respect to its product and process aspects.
a)結合剤系
本発明の組成物は、極性溶媒の存在で膨潤又は増粘し、口腔ケア使用向けに安全で審美的に快い基部を提供する結合剤系を含む。本結合剤系は、親水性粘土材、変性セルロースポリマー、カルボキシビニルポリマー及びアニオン性ポリマー由来の天然ゴム類を含み、その各々を以下に詳述する。特定の4つの結合剤材の組合せが、比較的少量の各結合剤、従って低コストで本歯磨剤組成物に対して好適なレオロジーを提供し、それと同時に種々の口腔ケア活性物質も包含できる。驚いたことに、本結合剤系は、研磨材を組成物の約10重量%未満等の低いレベルで使用し、及び実質的に研磨材を全く使用しないときでさえ安定な歯磨剤組成物を提供することを見出した。本結合剤系は、典型的な練り歯磨き形態の場合、T−Eスピンドルを有するB型粘度計で測定したとき約10,000Pa〜約450,000Pa、好ましくは約10,000Pa〜約250,000Paの好適な粘度を提供する。
a) Binder System The composition of the present invention comprises a binder system that swells or thickens in the presence of a polar solvent and provides a safe and aesthetically pleasing base for oral care use. The binder system includes natural rubbers derived from hydrophilic clay materials, modified cellulose polymers, carboxyvinyl polymers and anionic polymers, each of which is described in detail below. The combination of the four specific binder materials provides a suitable rheology for the dentifrice composition at a relatively low amount of each binder, and thus at a low cost, while also including various oral care actives. Surprisingly, the present binder system provides a dentifrice composition that uses an abrasive at a low level, such as less than about 10% by weight of the composition, and is stable even when substantially no abrasive is used. Found to provide. The binder system, in the typical toothpaste form, is from about 10,000 Pa to about 450,000 Pa, preferably from about 10,000 Pa to about 250,000 Pa, as measured with a B-type viscometer with a TE spindle. Provides a suitable viscosity.
4つの結合剤のそれぞれの量は、所望のレオロジー及び審美的特徴に基づき選択される。結合剤系の合計は、全組成物の好ましくは約0.1%〜約10%、より好ましくは約0.1%〜約5%、更に好ましくは約0.1%〜約3%である。 The amount of each of the four binders is selected based on the desired rheology and aesthetic characteristics. The total binder system is preferably from about 0.1% to about 10% of the total composition, more preferably from about 0.1% to about 5%, and even more preferably from about 0.1% to about 3%. .
a−i)親水性粘土材
本発明の組成物は、親水性粘土材を含む。親水性粘土材は、好ましくは全組成物の約0.01重量%〜約5重量%、より好ましくは約0.01重量%〜約4重量%で構成される。
ai) Hydrophilic clay material The composition of the present invention comprises a hydrophilic clay material. The hydrophilic clay material preferably comprises from about 0.01% to about 5%, more preferably from about 0.01% to about 4% by weight of the total composition.
本明細書で有用な親水性粘土材としては、天然及び合成層状ケイ酸塩鉱物類、ヒュームドシリカ類、増粘沈殿シリカ及びこれらの混合物が挙げられる。層状ケイ酸塩鉱物類は、自然に発生し、又は合成されてよく、鉱物の特定部分で置換されたマグネシウムを有する。ヒュームドシリカ類は、約5μm未満、典型的には約1ナノメートル〜約1μmの粒径を有する非常に小さい又は全く研磨機能を備えないものである。増粘沈殿シリカは、少なくとも約150mL/100g、好ましくは少なくとも約250mL/100gのDOA値、及び約1μm〜約50μmの粒径を有するものである。増粘沈殿シリカは、DOA値で定義されるようにその高い油吸収性により研磨シリカ材と区別できる。そのような特性が、増粘性を提供する。 Hydrophilic clay materials useful herein include natural and synthetic layered silicate minerals, fumed silicas, thickened precipitated silicas and mixtures thereof. Layered silicate minerals may be naturally occurring or synthesized and have magnesium substituted with specific parts of the mineral. Fumed silicas are those that have a particle size of less than about 5 μm, typically about 1 nanometer to about 1 μm, with very little or no polishing function. The thickened precipitated silica is one having a DOA value of at least about 150 mL / 100 g, preferably at least about 250 mL / 100 g, and a particle size of about 1 μm to about 50 μm. Thickened precipitated silica can be distinguished from abrasive silica materials by its high oil absorption as defined by the DOA value. Such characteristics provide thickening.
本明細書で有用な市販の親水性粘土材としては、ロックウッド・アディティブ社(Rockwood Additives Limited)及びサウザンクレー社(Southern Clay Company)から入手可能な商標名ラポナイト(LAPONITE)シリーズによる合成層状ケイ酸マグネシウム、カボット&デグッサ社(Cabot & Degussa Corporation)から入手可能な商標名エアゾール(AEROSOL)シリーズ及びカブ−オ−ジル(CAB-O-SIL)による約12ナノメートルの平均粒径を有するヒュームドシリカ、J.M.ハーバー社(Huber Company)からの商標名ゼオデント(ZEODENT)165及びグレースダビジョン(Grace Davision)からのシロックス(SYLOX)15による非晶質沈殿シリカ並びにローディア(Rhodia)からの商標名ティクソシル(TIXOSIL)による沈殿シリカが挙げられる。 Commercially available hydrophilic clay materials useful herein include synthetic layered silicates under the trade name LAPONITE series available from Rockwood Additives Limited and Southern Clay Company. Magnesium, fumed silica having an average particle size of about 12 nanometers according to the aerosol series AEROSOL and CAB-O-SIL available from Cabot & Degussa Corporation J. et al. M.M. Amorphous precipitated silica with the trade name ZEODENT 165 from Huber Company and SYLOX 15 from Grace Davision and the trade name TIXOSIL from Rhodia Precipitated silica is mentioned.
a−ii)変性セルロースポリマー
本発明の組成物は、変性セルロースポリマーを含む。変性セルロースポリマーは、好ましくは全組成物の約0.01重量%〜約5重量%、より好ましくは約0.01重量%〜約4.5重量%で構成される。
a-ii) Modified Cellulose Polymer The composition of the present invention comprises a modified cellulose polymer. The modified cellulose polymer is preferably comprised of about 0.01% to about 5%, more preferably about 0.01% to about 4.5% by weight of the total composition.
本明細書における変性セルロースポリマー類は、組成物に連続的な構造を構築するのに有用な結合剤材である。本明細書で有用な変性セルロースポリマー類としては、カルボキシメチルセルロースナトリウム、ポリビニルピロリドン、ヒドロキシエチルプロピルセルロース、ヒドロキシブチルメチルセルロース、ヒドロキシプロピルメチルセルロース及びヒドロキシエチルセルロースが挙げられる。特に有用な市販の材料としては、ハーキュレス(Hercules)からの商標名ブラノーズ(BLANOSE)シリーズ、オプティセル(OPTICEL)100及びアクアロン(AQUALON)シリーズによるカルボキシメチルセルロースナトリウム;ハーキュレス(Hercules)からの商標名クルセル(KLUCEL)シリーズによるヒドロキシエチルプロピルセルロース、イシング市(YIXING CITY)No.8ケミカルプラントからの商標名TF−E25及びハーキュレス(Hercules)からの商標名ベネセル(BENECEL)シリーズによるヒドロキシプロピルメチルセルロースが挙げられる。 The modified cellulose polymers herein are useful binder materials for building a continuous structure in the composition. Modified cellulose polymers useful herein include sodium carboxymethylcellulose, polyvinylpyrrolidone, hydroxyethylpropylcellulose, hydroxybutylmethylcellulose, hydroxypropylmethylcellulose and hydroxyethylcellulose. Particularly useful commercially available materials include sodium carboxymethylcellulose from the brand names BLANOSE, OPTICEL 100 and AQUALON series from Hercules; the brand name Kurcel from Hercules (Hercules) KLUCEL) series hydroxyethylpropylcellulose, YIXING CITY No. Hydroxylmethylcellulose according to the trade name TF-E25 from 8 chemical plants and the trade name BENECEL series from Hercules.
a−iii)カルボキシビニルポリマー
本発明の組成物は、カルボキシビニルポリマーを含む。カルボキシビニルポリマーは、好ましくは全組成物の約0.01重量%〜約5重量%、より好ましくは約0.01重量%〜約3重量%で構成される。
a-iii) Carboxyvinyl Polymer The composition of the present invention comprises a carboxyvinyl polymer. The carboxyvinyl polymer preferably comprises about 0.01% to about 5%, more preferably about 0.01% to about 3% by weight of the total composition.
本明細書において、カルボキシビニルポリマーは、上に開示した親水性粘土材と組合わせて三次元構造体をつくるための有用な結合剤材である。本明細書で有用なカルボキシビニルポリマーとしては、ノベオン社(Noveon Inc.)からのカーボポール(CARBOPOL)956、934、940、941、1342、ETD2020、ウルトレズ(ULTREZ)10”等の商品名カーボポール(CARBOPOL)シリーズ(又はカルボマー(CARBOMER))、B.F.グッドリッチ(Goodrich)からのカーボポール(CARBOPOL)934、940、974P及び3V社(3V Company)から入手可能なシンサレン(SYNTHALEN)Kによるものが挙げられる。 As used herein, carboxyvinyl polymer is a useful binder material for making a three-dimensional structure in combination with the hydrophilic clay material disclosed above. Carboxyvinyl polymers useful herein include: Carbopol 956, 934, 940, 941, 1342, ETD2020, ULTRAZ 10 ", etc. Carbopol from Noveon Inc. (CARBOPOL) series (or CARBOMER) by CARBOPOL 934, 940, 974P from BF Goodrich and SYNTHALEN K available from 3V Company Things.
a−iv)天然ゴム由来アニオン性ポリマー類
本発明の組成物は、天然ゴム由来アニオン性ポリマー類を含む。天然ゴム由来アニオン性ポリマー類は、好ましくは全組成物の約0.01重量%〜約5重量%、より好ましくは約0.01重量%〜約3重量%で構成される。
a-iv) Natural rubber-derived anionic polymers The composition of the present invention comprises natural rubber-derived anionic polymers. Natural rubber derived anionic polymers are preferably comprised of from about 0.01% to about 5%, more preferably from about 0.01% to about 3% by weight of the total composition.
本明細書において天然ガム由来のアニオン性ポリマー類は、粘性を有効に付加するのに有用な結合剤材である。本明細書で有用なアニオン性ポリマー由来の天然ゴム類としては、カラギーナン、キサンタンガム、ジェランガム及びイナゴマメゴムが挙げられる。特に有用な市販の材料としては、CPケルコ(Kelco)から入手可能な商標名ケルデント(KELDENT)シリーズ及びローディア(Rhodia)から商標名ローディケア(RHODICARE)によるキサンタンガム;CPケルコ(Kelco)からの商標名ケルコゲル(KELCOGEL)シリーズによるジェランガム;並びにFMCバイオポリマー(BioPolymer)からの商標名ゲロイド(GELLOID)LBによるローカストビーンガムが挙げられる。 As used herein, anionic polymers derived from natural gum are binder materials useful for effectively adding viscosity. Natural rubbers derived from anionic polymers useful herein include carrageenan, xanthan gum, gellan gum, and locust bean gum. Particularly useful commercially available materials include the brand name KELDENT series available from CP Kelco and the xanthan gum from Rhodia under the trade name Rhodicare; the trade name from CP Kelco Gellan gum according to the KELCOGEL series; and locust bean gum under the trade name GELLOID LB from FMC BioPolymer.
a−v)その他の結合剤
又、本明細書において、デンプン及びカラギーナンは、結合剤材として有用である。カラギーナンは、FMCバイオポリマー(BioPolymer)からの商標名ビスカリ(VISCARI)シリーズ及びゲルカリン(GELCARIN)シリーズ、メイホール社(Meyhall AG)からの商標名メイプロ−ゾル(MEYPRO-SOL)シリーズ並びにCPケルコ(Kelco)からの商標名ゲヌビスコ(GENUVISCO)シリーズ、ゲヌ(GENU)シリーズ及びゲヌチン(GENUTINE)シリーズにより市販されている。
a-v) Other Binders Also used herein, starch and carrageenan are useful as binder materials. Carrageenans are trade names from FMC Biopolymer (BioPolymer) and VISCARI series and GELCARIN series, trade names from Meyhall AG, MEYPRO-SOL series and CP Kelco. Under the trade names GENUVISCO series, GENU series and GENUTINE series.
b)口腔ケア活性物質
本発明の組成物は、意図した治療上の口腔ケア利益を提供する口腔ケア活性物質を含む。本明細書で有用な口腔ケア活性物質としては、抗結石剤類、スズイオン源類、フッ化物イオン源類、白化剤類、抗菌剤類、抗歯垢剤類、抗炎症剤類、栄養素類、酸化防止剤類、抗ウイルス薬類、鎮痛及び麻酔剤類、亜鉛含有層状物質及びこれらの混合物が挙げられる。
b) Oral Care Active Substance The composition of the present invention comprises an oral care active substance that provides the intended therapeutic oral care benefit. Oral care actives useful herein include anticalculus agents, tin ion sources, fluoride ion sources, whitening agents, antibacterial agents, anti-plaque agents, anti-inflammatory agents, nutrients, Antioxidants, antiviral drugs, analgesics and anesthetics, zinc-containing layered materials and mixtures thereof.
b−1)抗結石剤
本明細書で有用な口腔ケア剤としては、抗結石剤が挙げられ、それは、1つの実施形態において、口腔ケア組成物の約0.05重量%〜約50重量%、別の実施形態において、約0.05重量%〜約25重量%存在する。抗結石剤は、ポリホスフェート類(ピロホスフェート類を含む)及びそれらの塩類;ポリアミノプロパンスルホン酸(AMPS)及びその塩類;ポリオレフィンスルホネート類及びそれらの塩類;ポリビニルホスフェート類及びそれらの塩類;ポリオレフィンホスフェート類及びそれらの塩類;ジホスホネート類及びそれらの塩類;ホスホノアルカンカルボン酸及びその塩類;ポリホスホネート類及びそれらの塩類;ポリビニルホスホネート類及びそれらの塩類;ポリオレフィンホスホネート類及びそれらの塩類;ポリペプチド類;並びにこれらの混合物からなる群から選択されてもよい。一つの実施形態において、塩類はアルカリ金属塩類である。ポリホスフェート類は、一般に、カリウム塩、ナトリウム塩、アンモニウム塩及びこれらの混合物のような、全体的に又は部分的に中和された水溶性アルカリ金属塩類として使用される。無機ポリホスフェート塩類には、アルカリ金属(例えば、ナトリウム)トリポリホスフェート、テトラポリホスフェート、二酸ジアルキル金属(例えば、二ナトリウム)、一酸トリアルキル金属(例えば、三ナトリウム)、リン酸水素カリウム、リン酸水素ナトリウム、及びアルカリ金属(例えば、ナトリウム)ヘキサメタホスフェート、並びにこれらの混合物が挙げられる。テトラポリホスフェートよりも大きいポリホスフェート類は、通常は無定形のガラス状物質として生じる。一つの実施形態において、ポリホスフェート類は、FMC社(FMC Corporation)により製造されたものであり、ソダホス(Sodaphos)(n≒6)、ヘキサホス(n≒13)及びグラス(Glass)H(n≒21、ヘキサメタリン酸ナトリウム)及びこれらの混合物として商業的に周知である。本発明に有用なピロホスフェート塩類には、アルカリ金属ピロホスフェート類、ジ−、トリ−及びモノ−カリウム又はナトリウムピロホスフェート、ジアルカリ金属ピロホスフェート塩類、テトラアルカリ金属ピロホスフェート塩類、並びにこれらの混合物が挙げられる。一実施形態では、ピロホスフェート塩は、ピロリン酸三ナトリウム、ピロリン酸二水素二ナトリウム(Na2H2P2O7)、ピロリン酸二カリウム、ピロリン酸四ナトリウム(Na4P2O7)、ピロリン酸四カリウム(K4P2O7)、及びこれらの混合物からなる群より選択される。ポリオレフィンスルホネート類には、オレフィン基が2個以上の炭素原子を含有するもの及びそれらの塩が挙げられる。ポリオレフィンホスホネート類には、オレフィン基が2個以上の炭素原子を含有するものが挙げられる。ポリビニルホスホネート類には、ポリビニルホスホン酸が挙げられる。ジホスホネート類及びそれらの塩類には、アゾシクロアルカン−2,2−ジホスホン酸類及びこれらの塩類、アゾシクロアルカン−2,2−ジホスホン酸類のイオン類及びこれらの塩類、アザシクロヘキサン−2,2−ジホスホン酸、アザシクロペンタン−2,2−ジホスホン酸、N−メチル−アザシクロペンタン−2,3−ジホスホン酸、EHDP(エタン−1−ヒドロキシ−1,1−ジホスホン酸)、AHP(アザシクロヘプタン−2,2−ジホスホン酸)、エタン−1−アミノ−1,1−ジホスホネート、ジクロロメタン−ジホスホネートなどが挙げられる。ホスホノアルカンカルボン酸又はそのアルカリ金属塩類には、それぞれ酸又はアルカリ金属塩類として、PPTA(ホスホノプロパントリカルボン酸)、PBTA(ホスホノブタン−1,2,4−トリカルボン酸)が挙げられる。ポリオレフィンホスフェート類には、オレフィン基が2個以上の炭素原子を含有するものが挙げられる。他の有用な材料としては、例えば、米国特許第4,627,977号に記載されたようなポリアクリレート類、無水マレイン酸又は酸のコポリマー類及びメチルビニルエーテル(例えば、ガントレズ(Gantrez))並びに、例えばポリアミノプロパンスルホン酸(AMPS)、クエン酸亜鉛三水和物、ポリホスフェート類(例えば、トリポリホスフェート;ヘキサメタホスフェート)、ジホスホン酸エステル類(例えば、EHDP、AHP)、ポリペプチド類(ポリアスパラギン酸及びポリグルタミン酸)及びこれらの混合物を含む合成アニオン性ポリマー類が挙げられる加えて、口腔ケア組成物は、米国特許第6,682,722号及び同第6,589,512号、及び米国特許出願10/424,640及び10/430,617に記載されるもののようなポリマーキャリアを含むことができる。
b-1) Anticalculus Agents Oral care agents useful herein include anticalculus agents, which in one embodiment are from about 0.05% to about 50% by weight of the oral care composition. In another embodiment, from about 0.05% to about 25% by weight. Anticalculus agents include polyphosphates (including pyrophosphates) and salts thereof; polyaminopropane sulfonic acid (AMPS) and salts thereof; polyolefin sulfonates and salts thereof; polyvinyl phosphates and salts thereof; polyolefin phosphates Diphosphonates and salts thereof; phosphonoalkanecarboxylic acids and salts thereof; polyphosphonates and salts thereof; polyvinyl phosphonates and salts thereof; polyolefin phosphonates and salts thereof; polypeptides; As well as selected from the group consisting of these mixtures. In one embodiment, the salts are alkali metal salts. Polyphosphates are generally used as fully or partially neutralized water soluble alkali metal salts, such as potassium, sodium, ammonium and mixtures thereof. Inorganic polyphosphate salts include alkali metal (eg, sodium) tripolyphosphate, tetrapolyphosphate, dialkyl metal diacid (eg, disodium), trialkyl metal monoacid (eg, trisodium), potassium hydrogen phosphate, phosphorus Examples include sodium oxyhydrogen and alkali metal (eg, sodium) hexametaphosphate, and mixtures thereof. Polyphosphates larger than tetrapolyphosphate usually occur as amorphous glassy materials. In one embodiment, the polyphosphates are those manufactured by FMC Corporation, Sodaphos (n≈6), Hexaphos (n≈13) and Glass H (n≈ 21, sodium hexametaphosphate) and mixtures thereof. Pyrophosphate salts useful in the present invention include alkali metal pyrophosphates, di-, tri- and mono-potassium or sodium pyrophosphates, dialkali metal pyrophosphate salts, tetraalkali metal pyrophosphate salts, and mixtures thereof. It is done. In one embodiment, the pyrophosphate salt is trisodium pyrophosphate, disodium dihydrogen pyrophosphate (Na 2 H 2 P 2 O 7 ), dipotassium pyrophosphate, tetrasodium pyrophosphate (Na 4 P 2 O 7 ), Selected from the group consisting of tetrapotassium pyrophosphate (K 4 P 2 O 7 ), and mixtures thereof. Polyolefin sulfonates include those in which the olefin group contains 2 or more carbon atoms and salts thereof. Polyolefin phosphonates include those where the olefin group contains 2 or more carbon atoms. Polyvinyl phosphonates include polyvinyl phosphonic acid. Diphosphonates and their salts include azocycloalkane-2,2-diphosphonic acids and their salts, ions of azocycloalkane-2,2-diphosphonic acids and their salts, azacyclohexane-2,2- Diphosphonic acid, azacyclopentane-2,2-diphosphonic acid, N-methyl-azacyclopentane-2,3-diphosphonic acid, EHDP (ethane-1-hydroxy-1,1-diphosphonic acid), AHP (azacycloheptane) -2,2-diphosphonic acid), ethane-1-amino-1,1-diphosphonate, dichloromethane-diphosphonate and the like. Examples of the phosphonoalkanecarboxylic acid or alkali metal salts thereof include PPTA (phosphonopropane tricarboxylic acid) and PBTA (phosphonobutane-1,2,4-tricarboxylic acid) as acids or alkali metal salts, respectively. Polyolefin phosphates include those in which the olefin group contains two or more carbon atoms. Other useful materials include, for example, polyacrylates, maleic anhydride or acid copolymers and methyl vinyl ethers (eg, Gantrez) as described in US Pat. No. 4,627,977, and For example, polyaminopropane sulfonic acid (AMPS), zinc citrate trihydrate, polyphosphates (eg, tripolyphosphate; hexametaphosphate), diphosphonic acid esters (eg, EHDP, AHP), polypeptides (polyaspartic acid) And polyglutamic acid) and mixtures thereof, in addition, oral care compositions are described in US Pat. Nos. 6,682,722 and 6,589,512, and US patent applications. 10 / 424,640 and 10 / 430,617 Polymer carriers such as those can be included.
b−2)スズイオン源
本明細書で有用な口腔ケア剤は、スズイオン源を含む。スズイオンは、フッ化第一スズ及び/又は他のスズ塩類から提供されてもよい。フッ化第一スズは、歯肉炎、歯垢、敏感度の低減、及び改善された息の利益に役立つことが見出されている。口腔用組成物に提供されるスズイオン類は、組成物を使用する対象者に効能をもたらす。効能は、歯肉炎の低減以外の利益を含むことができるが、効能は、その場の歯垢代謝における顕著な低減の量として定義される。そのような効能をもたらす製剤は、典型的には、フッ化第一スズ及び/又は他のスズ塩類により提供され、組成物全体で約3,000ppm〜約15,000ppmのスズイオンの範囲である、スズ濃度を含む。約3,000ppm未満のスズではスズの有効性は十分ではない。スズイオンは、約4,000ppm〜約12,000ppm、一つの実施形態では、約5,000ppm〜約10,000ppmの量で存在する。他のスズ塩類には、酢酸第一スズ、グルコン酸第一スズ、シュウ酸第一スズ、マロン酸第一スズ、クエン酸第一スズ、第一スズエチレングリコキシド、ギ酸第一スズ、硫酸第一スズ、乳酸第一スズ、酒石酸第一スズなどのような有機カルボン酸第一スズ類が挙げられる。他のスズイオン供給源には、塩化第一スズ類、臭化第一スズ、ヨウ化第一スズ、及び塩化第一スズ二水素化物(dihydride)のようなスズハロゲン化物が挙げられる。一つの実施形態において、スズイオン供給源はフッ化第一スズであり、別の実施形態では、塩化第一スズ二水和物(stannous chloride dihydrate)である。合わせたスズ塩類は、組成物の約0.001重量%〜約11重量%の量で存在してもよい。スズ塩類は、組成物の、一つの実施形態では約0.01重量%〜約7重量%、別の実施形態では約0.1重量%〜約5重量%、別の実施形態では約1.5重量%〜約3重量%の量で存在してもよい。
b-2) Tin ion source The oral care agent useful herein includes a tin ion source. Tin ions may be provided from stannous fluoride and / or other tin salts. Stannous fluoride has been found to be useful for gingivitis, plaque, reduced sensitivity, and improved breath benefits. The tin ions provided in the oral composition provide efficacy to the subject using the composition. Efficacy can include benefits other than reducing gingivitis, but efficacy is defined as the amount of significant reduction in in situ plaque metabolism. Formulations that provide such efficacy are typically provided by stannous fluoride and / or other tin salts, ranging from about 3,000 ppm to about 15,000 ppm tin ions throughout the composition. Includes tin concentration. Tin less than about 3,000 ppm is not sufficient for tin. Tin ions are present in an amount from about 4,000 ppm to about 12,000 ppm, and in one embodiment from about 5,000 ppm to about 10,000 ppm. Other tin salts include stannous acetate, stannous gluconate, stannous oxalate, stannous malonate, stannous citrate, stannous ethylene glycoloxide, stannous formate, stannous sulfate Organic stannous carboxylic acids such as stannous, stannous lactate, stannous tartrate and the like. Other tin ion sources include stannous chlorides, stannous bromides, stannous iodide, and tin halides such as stannous chloride dihydride. In one embodiment, the tin ion source is stannous fluoride, and in another embodiment, stannous chloride dihydrate. The combined tin salts may be present in an amount from about 0.001% to about 11% by weight of the composition. The tin salt is about 0.01% to about 7% by weight of the composition in one embodiment, about 0.1% to about 5% by weight in another embodiment, about 1.% by weight in another embodiment. It may be present in an amount of 5% to about 3% by weight.
b−3)フッ化物イオン源
本明細書で有用な口腔ケア剤は、フッ化物イオン源を含み抗カリエス効果を提供する。これらの物質に含まれるのは、可溶性アルカリ金属フッ化物塩類、例えばフッ化ナトリウム、フッ化カリウム、モノフルオロリン酸ナトリウム及びヘキサフルオロケイ酸ナトリウム等の無機フッ化物塩類である。フッ化ナトリウム、モノフルオロリン酸ナトリウム、ヘキサフルオロケイ酸ナトリウム及びこれらの混合物等のアルカリ金属フッ化物類が好ましい。
b-3) Fluoride Ion Source Useful oral care agents herein include a fluoride ion source and provide an anti-caries effect. Included in these materials are soluble alkali metal fluoride salts, such as inorganic fluoride salts such as sodium fluoride, potassium fluoride, sodium monofluorophosphate and sodium hexafluorosilicate. Alkali metal fluorides such as sodium fluoride, sodium monofluorophosphate, sodium hexafluorosilicate and mixtures thereof are preferred.
フッ素供与塩の量は、一般に約0.0〜約3.0重量%の濃度で口腔用組成物中に存在する。そのような塩の任意の好適な最小量が使用されてよいが、十分なフッ化物塩を使用し、約50ppm〜約3500ppm、好ましくは約300ppm〜約2,000ppmのフッ化物イオンを放出するのが好ましい。 The amount of fluorine donor salt is generally present in the oral composition at a concentration of about 0.0 to about 3.0% by weight. Any suitable minimum amount of such salts may be used, but sufficient fluoride salt is used to release about 50 ppm to about 3500 ppm, preferably about 300 ppm to about 2,000 ppm fluoride ions. Is preferred.
b−4)白化剤
本明細書で有用な口腔ケア剤は、白化剤を含む。白化に好適な活性物質類は、アルカリ金属及びアルカリ土類金属過酸化物類、金属亜塩素酸塩類、モノ及び四水和物を含む過ホウ酸塩類、過リン酸塩類(perphoshates)、過炭酸塩類、ペルオキシ酸類、過硫酸アンモニウム、過硫酸カリウム、過硫酸ナトリウム及び過硫酸リチウム等のアルカリ金属過硫酸塩類並びにこれらの混合物から成る群から選択される。好適な過酸化物化合物には、過酸化水素、過酸化尿素、過酸化カルシウム、過酸化カルバミド、過酸化マグネシウム、過酸化亜鉛、過酸化ストロンチウム、及びこれらの混合物が挙げられる。一つの実施形態において、過酸化物化合物は過酸化カルバミドである。好適な亜塩素酸金属塩には、亜塩素酸カルシウム、亜塩素酸バリウム、亜塩素酸マグネシウム、亜塩素酸リチウム、亜塩素酸ナトリウム、及び亜塩素酸カリウムが挙げられる。追加的白化活性物質は、次亜塩素酸塩及び二酸化塩素であってもよい。一つの実施形態において、亜塩素酸塩は亜塩素酸ナトリウムである。別の実施形態において、過炭酸塩は過炭酸ナトリウムである。一つの実施形態では、過硫酸塩類はオキソン類である。これらの物質の濃度は、分子が、染みを漂白するために提供できる、利用可能な酸素又は塩素それぞれによって左右される。一つの実施形態において、白化剤は、組成物の約0.01重量%〜約40重量%、別の実施形態では、約0.1重量%〜約20重量%、別の実施形態では約0.5重量%〜約10重量%、別の実施形態では約4重量%〜約7重量%の濃度で存在してもよい。
b-4) Whitening Agent The oral care agent useful herein includes a whitening agent. Suitable active substances for whitening are alkali metal and alkaline earth metal peroxides, metal chlorites, perborates including mono- and tetrahydrates, perphosphates, percarbonate Selected from the group consisting of salts, peroxy acids, ammonium persulfate, potassium persulfate, alkali metal persulfates such as sodium persulfate and lithium persulfate, and mixtures thereof. Suitable peroxide compounds include hydrogen peroxide, urea peroxide, calcium peroxide, carbamide peroxide, magnesium peroxide, zinc peroxide, strontium peroxide, and mixtures thereof. In one embodiment, the peroxide compound is carbamide peroxide. Suitable metal chlorites include calcium chlorite, barium chlorite, magnesium chlorite, lithium chlorite, sodium chlorite, and potassium chlorite. Additional whitening actives may be hypochlorite and chlorine dioxide. In one embodiment, the chlorite is sodium chlorite. In another embodiment, the percarbonate is sodium percarbonate. In one embodiment, the persulfates are oxones. The concentration of these materials depends on the available oxygen or chlorine, respectively, that the molecule can provide to bleach the stain. In one embodiment, the whitening agent is from about 0.01% to about 40% by weight of the composition, in another embodiment from about 0.1% to about 20%, in another embodiment about 0%. It may be present at a concentration of from 5 wt% to about 10 wt%, in another embodiment from about 4 wt% to about 7 wt%.
b−5)抗菌剤
本明細書で有用な口腔ケア剤は、他の抗菌剤を含む。前記剤としては、通常トリクロサンと呼ばれる5−クロロ−2−(2,4−ジクロロフェノキシ)−フェノール;8−ヒドロキシキノリン及びその塩類;塩化銅(II)、硫酸銅(II)、酢酸銅(II)、フッ化銅(II)及び水酸化銅(II)を含むがこれらに限定されない銅II化合物類;マグネシウムフタル酸モノカリウムを含む米国特許第4,994,262号に開示されたものを含むがこれらに限定されないフタル酸及びその塩類;クロルヘキシジン;アレキシジン;ヘキセチジン;サンギナリン;塩化ベンザルコニウム;サリチルアニリド;臭化ドミフェン;塩化セチルピリジニウム(CPC);塩化テトラデシルピリジニウム(TPC);塩化N−テトラデシル−4−エチルピリジニウム(TDEPC);オクテニジン(octenidine);ヨード;スルファニルアミド類;ビスビグアナイド類;フェノール類;デルモピノール(delmopinol)、オクタピノール(octapinol)及び他のピペリジノ誘導体類;ナイアシン製剤類;酸化亜鉛、乳酸亜鉛及びクエン酸亜鉛等の亜鉛又はスズイオン剤;ナイスタチン;グレープフルーツ抽出物;リンゴ抽出物;タイム油;チモール;オウグメンチン、アモキシシリン、テトラサイクリン、ドキシサイクリン、ミノサイクリン、メトロニダゾル、ネオマイシン、カナマイシン、塩化セチルピリジニウム及びクリンダマイシン等の抗生物質類;上記の類似物及び塩;チモール、ゲラニオール、カルバクロール、シトラール、ヒノキチオール、ユーカリプトール、カテコール(特に4−アリルカテコール)及びこれらの混合物を含む芳香油類;サリチル酸メチル;過酸化水素;亜塩素酸の金属塩類;並びに上記の全ての混合物が挙げられてよいが、これらに限定されない。抗菌剤構成成分は、組成物の約0.001重量%〜約20重量%存在してよい。
b-5) Antibacterial agents The oral care agents useful herein include other antibacterial agents. Examples of the agent include 5-chloro-2- (2,4-dichlorophenoxy) -phenol, usually called triclosan; 8-hydroxyquinoline and its salts; copper chloride (II), copper sulfate (II), copper acetate (II ), Copper (II) fluoride and copper (II) hydroxide, including but not limited to copper II compounds; including those disclosed in US Pat. No. 4,994,262 including monopotassium magnesium phthalate Phthalic acid and salts thereof, including but not limited to: chlorhexidine; alexidine; hexetidine; sanguinarine; benzalkonium chloride; salicylanilide; domifene bromide; cetylpyridinium chloride (CPC); tetradecylpyridinium chloride (TPC); N-tetradecyl chloride -4-ethylpyridinium (TDEPC); octenidine (octe) iodine; sulfanilamides; bisbiguanides; phenols; delmopinol, octapinol and other piperidino derivatives; niacin formulations; zinc or tin ions such as zinc oxide, zinc lactate and zinc citrate Nystatin; grapefruit extract; apple extract; thyme oil; thymol; And fragrance oils containing thymol, geraniol, carvacrol, citral, hinokitiol, eucalyptol, catechol (particularly 4-allylcatechol) and mixtures thereof; Examples include, but are not limited to, methyl lithylate; hydrogen peroxide; metal salts of chlorous acid; and mixtures of all of the above. The antimicrobial component may be present from about 0.001% to about 20% by weight of the composition.
b−6)抗歯垢剤
本明細書で有用な口腔ケア剤は、ジメチルイソソルビド、銅塩類、ストロンチウム塩類、マグネシウム塩類又はジメチコンコポリオール等の他の抗歯垢剤を含む。ジメチコンコポリオールは、C12〜C20アルキルジメチコンコポリオール及びこれらの混合物から選択される。一つの実施形態において、ジメチコンコポリオールは、商標名アビル(Abil)EM90で市販されているセチルジメチコンコポリオールである。ジメチコンコポリオールは、一つの実施形態において、組成物の約0.001重量%〜約25重量%、別の実施形態では、約0.01重量%〜約5重量%、別の実施形態では約0.1重量%〜約1.5重量%の濃度で存在することができる。
b-6) Anti-plaque Agents Oral care agents useful herein include other anti-plaque agents such as dimethyl isosorbide, copper salts, strontium salts, magnesium salts or dimethicone copolyol. The dimethicone copolyol is selected from C12 to C20 alkyl dimethicone copolyols and mixtures thereof. In one embodiment, the dimethicone copolyol is a cetyl dimethicone copolyol marketed under the trade name Abil EM90. The dimethicone copolyol in one embodiment is about 0.001% to about 25% by weight of the composition, in another embodiment about 0.01% to about 5%, in another embodiment about It can be present at a concentration of 0.1% to about 1.5% by weight.
b−7)抗炎症剤
本明細書で有用な口腔ケア剤は、抗炎症剤を含む。このような剤には、非ステロイド性抗炎症剤オキシカム類、サリチラート類、プロピオン酸類、酢酸類及びフェナメート類を挙げてもよいが、これらに限定されない。このようなNSAID類には、ケトロラク、フルルビプロフェン、イブプロフェン、ナプロキセン、インドメタシン、ジクロフェナク、エトドラク、インドメタシン、スリンダク、トルメチン、ケトプロフェン、フェノプロフェン、ピロキシカム、ナブメトン、アスピリン、ジフルニサル、メクロフェナム酸、メフェナム酸、オキシフェンブタゾン、フェニルブタゾン、及びアセトアミノフェンが挙げられるが、これらに限定されない。ケトロラクのようなNSAID類の使用は、米国特許第5,626,838号で特許請求されている。そこで開示されているものは、NSAIDの有効量の口腔又は中咽頭への局所投与によって、口腔又は口腔咽頭の原発性及び再発性の扁平上皮細胞癌を予防及び/又は治療する方法である。好適なステロイド性抗炎症剤には、フルオシノロン(fluccinolone)及びヒドロコルチゾンのような副腎皮質ホルモン類が挙げられる。
b-7) Anti-inflammatory agents The oral care agents useful herein include anti-inflammatory agents. Such agents may include, but are not limited to, non-steroidal anti-inflammatory drugs oxicams, salicylates, propionic acids, acetic acids and phenamates. Such NSAIDs include ketorolac, flurbiprofen, ibuprofen, naproxen, indomethacin, diclofenac, etodolac, indomethacin, sulindac, tolmetine, ketoprofen, fenoprofen, piroxicam, nabumetone, aspirin, diflunisal, meclofenamic acid, mefenamic acid , Oxyphenbutazone, phenylbutazone, and acetaminophen. The use of NSAIDs such as ketorolac is claimed in US Pat. No. 5,626,838. What is disclosed there is a method for preventing and / or treating primary and recurrent squamous cell carcinoma of the oral cavity or oropharynx by local administration of an effective amount of NSAID to the oral cavity or oropharynx. Suitable steroidal anti-inflammatory agents include corticosteroids such as fluccinolone and hydrocortisone.
b−8)栄養素類
本明細書で有用な口腔ケア剤は、口腔の状態を改善する栄養素類を含む。栄養素には、ミネラル、ビタミン、経口栄養補給剤、経腸栄養補給剤、及びこれらの混合物が挙げられる。有用なミネラル類には、カルシウム、リン、亜鉛、マンガン、カリウム、及びこれらの混合物が挙げられる。ビタミン類は、ミネラル類と共に包含されることができるか、又は別個に使用されることもできる。好適なビタミン類には、ビタミンC及びD、チアミン、リボフラビン、パントテン酸カルシウム、ナイアシン、葉酸、ニコチンアミド、ピリドキシン、シアノコバラミン、パラ−アミノ安息香酸、バイオフラボノイド類、及びこれらの混合物が挙げられる。経口栄養補給剤には、アミノ酸類、脂肪親和物質、魚油、及びこれらの混合物が挙げられる。アミノ酸類には、L−トリプトファン、L−リジン、メチオニン、スレオニン、レボカルニチン又はL−カルニチン及びこれらの混合物が挙げられるが、それらには限定されない。脂肪親和物質には、コリン、イノシトール、ベタイン、リノール酸、リノレン酸、及びこれらの混合物が挙げられるが、それらには限定されない。魚油は、大量のオメガ3(N−3)多不飽和脂肪酸類、エイコサペンタエン酸及びドコサヘキサエン酸を含有する。経腸栄養補給剤には、タンパク質製品、グルコースポリマー類、コーン油、ベニバナ油、中鎖トリグリセリド類が挙げられるが、それらには限定されない。ミネラル類、ビタミン類、経口栄養補給剤及び経腸栄養補給剤が、薬剤の事実と比較(Drug Facts and Comparisons)(ルーズリーフ式薬剤インフォメーションサービス(loose leaf drug information service))ミズリー州セントルイス(St. Louis)、ウォルターズ・クルワー社(Wolters Kluer Company)(著作権)1997年、3〜17及び54〜57頁により詳細に記載されている。
b-8) Nutrients Oral care agents useful herein include nutrients that improve oral conditions. Nutrients include minerals, vitamins, oral nutritional supplements, enteral nutritional supplements, and mixtures thereof. Useful minerals include calcium, phosphorus, zinc, manganese, potassium, and mixtures thereof. Vitamins can be included with minerals or can be used separately. Suitable vitamins include vitamins C and D, thiamine, riboflavin, calcium pantothenate, niacin, folic acid, nicotinamide, pyridoxine, cyanocobalamin, para-aminobenzoic acid, bioflavonoids, and mixtures thereof. Oral supplements include amino acids, lipophilic substances, fish oils, and mixtures thereof. Amino acids include, but are not limited to, L-tryptophan, L-lysine, methionine, threonine, levocarnitine or L-carnitine and mixtures thereof. Lipophilic substances include, but are not limited to, choline, inositol, betaine, linoleic acid, linolenic acid, and mixtures thereof. Fish oil contains large amounts of omega-3 (N-3) polyunsaturated fatty acids, eicosapentaenoic acid and docosahexaenoic acid. Enteral nutritional supplements include, but are not limited to, protein products, glucose polymers, corn oil, safflower oil, and medium chain triglycerides. Minerals, vitamins, oral and enteral nutritional supplements, Drug Facts and Comparisons (loose leaf drug information service), St. Louis, Missouri ), Wolters Kluer Company (Copyright) 1997, pages 3-17 and 54-57.
b−9)酸化防止剤類
本明細書で有用な口腔ケア剤は、酸化防止剤類を含む。酸化防止剤類は、カデナス&パッカー(Cadenas and Packer)等のテキスト、マーセル・デッカー社(Marcel Dekker, Inc)による酸化防止剤便覧(The Handbook of Antioxidants)(著作権)1996年に開示されている。本発明に有用な酸化防止剤には、ビタミンE、アスコルビン酸、尿酸、カロチノイド類、ビタミンA、フラボノイド類及びポリフェノール類、薬草抗酸化剤、メラトニン、アミノインドール類、リポ酸類及びこれらの混合物が挙げられるが、それらには限定されない。
b-9) Antioxidants The oral care agents useful herein include antioxidants. Antioxidants are disclosed in text by Cadenas and Packer et al., The Handbook of Antioxidants (Copyright) 1996 by Marcel Dekker, Inc. . Antioxidants useful in the present invention include vitamin E, ascorbic acid, uric acid, carotenoids, vitamin A, flavonoids and polyphenols, herbal antioxidants, melatonin, aminoindoles, lipoic acids and mixtures thereof. However, it is not limited to them.
b−10)抗ウイルス薬類
本明細書で有用な口腔ケア剤は、ウイルス感染を治療するために使用される抗ウイルス薬類を含む。前記抗ウイルス薬類としては、ホスホノ蟻酸;シオシン(cyosine)誘導体類;アデノシン、グアノシン及びイノシン類似体類等のプリン類似体類;シチジン(citidine)及びチミジン等のピリミジン塩基類;アマンタジン類;リマンタジンHCl;リバビリン;ザナミビル;オセルタミビルホスフェート;トリフルリジン(trifluridine):複素環式染料ルイ;アシクロビール;ファムシクロビール(famciclovir);バラシクロビール(valacyclovir);シドフォビール(cidofovir);ガンシクロビール;レバミゾール(levimisole);イドクスウリジン;親油性β−ケトン類;及びチオセミカルバゾン類が挙げられるがこれらに限定されない。これらの抗ウイルス薬類は、薬剤の事実と比較(Drug Facts and Comparisons)(ルーズリーフ式薬剤インフォメーションサービス(loose leaf drug information service))ミズリー州セントルイス(St. Louis)、ウォルターズ・クルワー社(Wolters Kluer Company)(著作権)2001年、1400〜1423(b)頁及びカーク−オスマー(Kirk-Othmer)、工業化学百科事典(Encyclopedia of Chemical Technology)第4版、第3巻、ワイリー−インターサイエンス・パブリッシャーズ(Wiley-Interscience Publishers)(1992年)576〜607頁に記載されている。
b-10) Antiviral drugs Useful oral care agents herein include antiviral drugs used to treat viral infections. Examples of the antiviral drugs include phosphonoformic acid; cyosine derivatives; purine analogs such as adenosine, guanosine and inosine analogs; pyrimidine bases such as cytidine and thymidine; amantadine; rimantadine HCl Ribavirin; zanamivir; oseltamivir phosphate; trifluridine: heterocyclic dye Louis; acyclovir; famciclovir; valacyclovir; cidofovir; ganciclovir; levimisole ); Idoxuridine; lipophilic β-ketones; and thiosemicarbazones, but are not limited to. These antiviral drugs are drug Facts and Comparisons (loose leaf drug information service), St. Louis, Missouri, Wolters Kluer Company (Copyright) 2001, pages 1400-1423 (b) and Kirk-Othmer, Encyclopedia of Chemical Technology, 4th edition, Volume 3, Wiley-Interscience Publisher (Wiley-Interscience Publishers) (1992), pages 576-607.
b−11)鎮痛剤及び麻酔剤
本明細書で有用な口腔ケア剤は、鎮痛剤又は減感剤を含む。鎮痛剤は、意識を撹乱させることなく、又はその他の感覚様相を変えることなく、痛みの閾値を上げるように中枢的に作用することによって痛みを緩和する剤である。そのような剤には、塩化ストロンチウム;硝酸カリウム;フッ化ナトリウム;硝酸ナトリウム;アセトアニリド;フェナセチン;アセルトファン(acertophan);チオルファン;スピラドリン(spiradoline);アスピリン;コデイン;テバイン;ラボルフェノール(levorphenol);ヒドロモルフォン;オキシモルフォン;フェナゾシン;フェンタニール;ブプレノルフィン;ブタファノール(butaphanol);ナルブフィン;ペンタゾシン;没食子のような自然の薬草類;アサルム;クベビン;ガランガ;スクテラリア;両面針;及び白止を挙げてもよいが、それらには限定されない。アセトアミノフェン、サリチル酸ナトリウム、サリチル酸トロラミン、リドカイン及びベンゾカインのような麻酔剤又は局所鎮痛剤もまた存在してもよい。これらの鎮痛活性剤は、カーク・オスマー(Kirk-Othmer)、工業化学百科事典(Encyclopedia of Chemical Technology)、第4版、2巻、ワイリー−インターサイエンス・パブリッシャーズ(Wiley-Interscience Publishers)(1992年)、729〜737頁に、詳細に記載されている。
b-11) Analgesics and Anesthetics Useful oral care agents herein include analgesics or desensitizers. An analgesic is an agent that relieves pain by acting centrally to raise the threshold of pain without disturbing consciousness or changing other sensory aspects. Such agents include: Strontium chloride; Potassium nitrate; Sodium fluoride; Sodium nitrate; Acetanilide; Phenacetin; Acertophan; Thiorphan; Spiradoline; Aspirin; Codeine; Thebaine; Oxymorphone; phenazosin; fentanyl; buprenorphine; butaphanol; nalbuphine; pentazocine; natural herbs such as gallic; asalum; cubine; galanga; scutaria; Is not limited. Anesthetics or topical analgesics such as acetaminophen, sodium salicylate, trolamine salicylate, lidocaine and benzocaine may also be present. These analgesic active agents are described by Kirk-Othmer, Encyclopedia of Chemical Technology, 4th edition, Volume 2, Wiley-Interscience Publishers (1992). ), Pages 729-737.
b−12)亜鉛含有層状材料
本明細書で有用な口腔ケア剤は、高亜鉛反応活性度のため有効な抗菌剤及び抗歯肉炎利益を有する亜鉛含有層状物質である。特に本明細書で有用なこれらの亜鉛含有層状物質は、約25%を超える相対亜鉛反応活性度を有するものであり、約20μ未満の平均粒径と高表面積を有する。一つの好ましい実施形態において、本明細書における亜鉛含有層状物質は、下記で議論するようにアニオン性界面活性剤を含有する組成物に組み入れられる。
b-12) Zinc-Containing Layered Material The oral care agents useful herein are zinc-containing layered materials that have effective antibacterial and anti-gingivitis benefits due to high zinc reaction activity. In particular, these zinc-containing layered materials useful herein are those having a relative zinc reaction activity of greater than about 25% and have an average particle size of less than about 20 microns and a high surface area. In one preferred embodiment, the zinc-containing layered material herein is incorporated into a composition containing an anionic surfactant as discussed below.
亜鉛反応活性度は、亜鉛イオンの化学的利用能の基準である。溶液中で他の種と錯体を形成しない可溶性亜鉛塩は、定義上、100%の相対亜鉛反応活性度を有する。ある程度可溶性の形態の亜鉛塩を使用し、及び/又は錯体を形成可能な種(potential complexants)と共にマトリックス中に組み込むと、一般に亜鉛反応活性度は、定義された100%最大値のかなり下まで低下する。有効な亜鉛含有層状物質の選択によって、又は既知の方法により有効な亜鉛含有層状物質をその場で生じさせることによって、反応活性度の高い亜鉛が維持される。 Zinc reaction activity is a measure of the chemical availability of zinc ions. Soluble zinc salts that do not complex with other species in solution, by definition, have a relative zinc reaction activity of 100%. When zinc salts in a somewhat soluble form are used and / or incorporated into the matrix with potential complexants, the zinc reaction activity generally decreases well below the defined 100% maximum. To do. Highly reactive zinc is maintained by selection of an effective zinc-containing layered material or by generating an effective zinc-containing layered material in situ by known methods.
亜鉛反応活性度は、希釈亜鉛含有溶液又は分散液と金属クロム染料キシレノールオレンジ(XO)とを組み合わせ、特定条件下で色の変化の程度を測定することによって評価する。色形成の大きさは、反応活性度の高い亜鉛の濃度に比例する。開発された手順は、水性界面活性剤製剤について最適化されているが、他の物理製品形態にも同様に適応できる。 The zinc reaction activity is evaluated by combining a diluted zinc-containing solution or dispersion and the metal chromium dye xylenol orange (XO) and measuring the degree of color change under specific conditions. The magnitude of color formation is proportional to the concentration of zinc with high reaction activity. The developed procedure has been optimized for aqueous surfactant formulations, but can be applied to other physical product forms as well.
分光光度計を使用して、XOに関して最適な色変化の波長である572nmでの色の変化を定量する。分光光度計は、潜在的に反応度の高い形態の亜鉛以外を除く、試験製品の組成に近い製品対照を利用して、572nmでの吸光度を0に設定する。次いで、対照及び試験製品を、次のように同様に処理する。50μLの製品試料を瓶に分配し、95mLの脱気した蒸留水を添加し、攪拌する。pH5.0にて5mLの23mg/mLキシレノールオレンジ原液をピペットで試料瓶に移し、この時間を0と考える。次に、希薄HCl又はNaOHを使用し、pHを5.50±0.01に調節する。10.0分後、試料の一部を濾過し(0.45μ)、吸光度を572nmで測定する。次いで、測定した吸光度を、別に測定した対照と比較して相対亜鉛反応活性度(0〜100%)を決定する。100%反応活性度の対照を、亜鉛基準で等濃度にて組み込まれた可溶性亜鉛物質(例えば硫酸亜鉛)の利用を除いて、試験製品と同様にマトリックスに調製する。100%反応活性度の対照の吸光度を、上記で試験物質について測定したように測定する。相対亜鉛反応活性度は、好ましくは約15%より高く、より好ましくは約20%より高く、更に好ましくは約25%よりも高い。 A spectrophotometer is used to quantify the color change at 572 nm, the wavelength of the optimal color change for XO. The spectrophotometer utilizes a product control close to the composition of the test product, except for the potentially reactive form of zinc, and sets the absorbance at 572 nm to zero. Controls and test products are then treated similarly as follows. Dispense 50 μL of the product sample into a jar, add 95 mL of degassed distilled water and stir. Pipette 5 mL of 23 mg / mL xylenol orange stock solution at pH 5.0 and consider this time as zero. The pH is then adjusted to 5.50 ± 0.01 using dilute HCl or NaOH. After 10.0 minutes, a portion of the sample is filtered (0.45 μ) and the absorbance is measured at 572 nm. The measured absorbance is then compared to a separately measured control to determine relative zinc reaction activity (0-100%). A 100% reaction activity control is prepared in a matrix similar to the test product, except for the use of soluble zinc material (eg, zinc sulfate) incorporated at equal concentrations on a zinc basis. The absorbance of the 100% reaction activity control is measured as measured above for the test substance. The relative zinc reaction activity is preferably greater than about 15%, more preferably greater than about 20%, and even more preferably greater than about 25%.
この方法を使用して、以下の実施例は、固有の反応活性度が低い物質(ZnO)と比較して、アニオン性界面活性剤系での反応活性度が本質的に高い物質(塩基性炭酸亜鉛)を実証する。
亜鉛含有層状構造は、主として二次元で生じる結晶成長を有するものである。層構造は、全ての原子が明確な層に組み込まれているものとしてだけではなく、ギャラリーイオン(gallery ion)と呼ばれる、層の間にイオン又は分子があるものとすることが慣例的である(A.F.ウェルズ(A. F. Wells)の「構造無機化学(Structural Inorganic Chemistry)」、クラレンドン出版(Clarendon Press)、1975年)。亜鉛含有層状物質(ZLM)は、亜鉛を層に組み込んで有してもよく、及び/又はギャラリーイオンの構成成分であってもよい。 Zinc-containing layered structures have crystal growth that occurs primarily in two dimensions. It is customary for the layer structure not only to have all atoms incorporated into a well-defined layer, but also to have ions or molecules between the layers, called gallery ions ( AF Wells, “Structural Inorganic Chemistry”, Clarendon Press, 1975). The zinc-containing layered material (ZLM) may have zinc incorporated into the layer and / or may be a component of gallery ions.
多くのZLMが鉱物として自然発生する。一般例としては、水亜鉛鉱(炭酸水酸化亜鉛)、塩基性炭酸亜鉛、水亜鉛銅鉱(炭酸水酸化銅亜鉛)、亜鉛孔雀石(炭酸水酸化亜鉛銅)、及び亜鉛が含まれている多くの関連する鉱物が挙げられる。天然のZLMもまた発生可能であり、その際、粘土型鉱物(例えばフィロシリケート)のようなアニオン性層の種には、イオン交換した亜鉛ギャラリーイオンが含有されている。これらの天然物質の全てはまた、合成的に得ることもでき、又は組成物中にその場で若しくは製造プロセスの間に生じさせることもできる。 Many ZLMs occur naturally as minerals. Common examples include hydrozinc ore (zinc carbonate hydroxide), basic zinc carbonate, hydrozinc copper ore (zinc carbonate carbonate), zinc peacock stone (zinc carbonate copper), and many Related minerals. Natural ZLM can also be generated, where anionic layer species such as clay-type minerals (eg phyllosilicates) contain ion exchanged zinc gallery ions. All of these natural materials can also be obtained synthetically or can be generated in situ in the composition or during the manufacturing process.
多くの場合合成であるが合成であるとは限らないZLMの他の一般の種類は、二重層状水酸化物であり、一般に式[M2+1−xM3+x(OH)2]x+Am−x/m・nH20で表わされ、二価イオン(M2+)の一部又は全てが亜鉛イオンで表わされる(EL.クレパルディ(Crepaldi)、PC.パバ(Pava)、J.トロント(Tronto)、JB.バリム(Valim)、J.Colloid Interfac.Sci.2002年、248、429〜42頁)。 Another common type of ZLM, which is often synthetic but not necessarily synthetic, is a double layered hydroxide, generally of the formula [M2 + 1−xM3 + x (OH) 2] x + Am−x / m · nH20 And some or all of the divalent ions (M2 +) are represented by zinc ions (EL. Crepaldi, PC. Pava, J. Toronto, JB. Valim). , J. Colloid Interfac. Sci. 2002, 248, 429-42).
ヒドロキシ複塩と呼ばれる、ZLMの更に他の種類を調製することができる(H.モリオカ(Morioka,H.)、H.タガヤ(Tagaya,H.)、M.カラス(Karasu,M)、J.カドカワ(Kadokawa,J)、K.チバ(Chiba,K)、無機化学(Inorg.Chem.)、1999年、38、4211〜6)。無機化学(Inorg.Chem.)、1999年、38、4211〜6)。ヒドロキシ複塩は、一般式[M2+1−xM2+1+x(OH)3(1−y)]+An−(1=3y)/n・nH20(式中、2つの金属イオンは異なっていてよく、それらが同じで亜鉛で表わされる場合、式は[Zn1+x(OH)2]2x+2xA−・nH20に簡略化される)で表わすことができる。この後者の式(式中、x=0.4)は、ヒドロキシ塩化亜鉛及びヒドロキシ硝酸亜鉛のような一般物質を表す。これらは水亜鉛鉱にも関連し、その際、二価のアニオンは一価のアニオンを置き換える。これらの物質はまた、組成物中にその場で又は製造プロセスの間に生じさせることもできる。 Still other types of ZLM, referred to as hydroxy double salts, can be prepared (H. Morioka, H., H. Tagaya, H., M. Karasu, M., J. Am. Kadokawa, J, K. Chiba, K, Inorganic Chemistry (Inorg. Chem.), 1999, 38, 4211-6). Inorganic chemistry (Inorg. Chem.), 1999, 38, 4211-6). The hydroxy double salt has the general formula [M2 + 1−xM2 + 1 + x (OH) 3 (1-y)] + An− (1 = 3y) / n · nH20 (wherein the two metal ions may be different and they are the same When expressed in zinc, the formula can be expressed as [Zn1 + x (OH) 2] 2x + 2xA-.nH20). This latter formula (where x = 0.4) represents general substances such as hydroxy zinc chloride and hydroxy zinc nitrate. These are also related to hydrozincite, where the divalent anion replaces the monovalent anion. These materials can also be generated in the composition in situ or during the manufacturing process.
ZLMのこれらの種類は、一般カテゴリーの比較的一般的な例を表すが、この定義に合うより広範囲の物質に関する限定を意図するものではない。 These types of ZLM represent a relatively general example of the general category, but are not intended to be a limitation on a wider range of materials that meet this definition.
塩基性炭酸亜鉛の市販の供給源には、炭酸亜鉛塩基(Zinc Carbonate Basic)(ケイター・ケミカルズ(Cater Chemicals):米国イリノイ州ベンセンビル)、炭酸亜鉛(Zinc Carbonate)(シェパード・ケミカルズ(Shepherd Chemicals):米国オハイオ州ノーウッド)、炭酸亜鉛(Zinc Carbonate)(CPSユニオン社(CPS Union Corp.):米国ニューヨーク州ニューヨーク)、炭酸亜鉛(Zinc Carbonate)(エレメンティス・ピグメンツ(Elementis Pigments):英国ダーラム)、及び炭酸亜鉛AC(Zinc Carbonate AC)(ブリュッグマン・ケミカル(Bruggemann Chemical):米国ペンシルベニア州ニュータウンスクエア)が挙げられる。 Commercial sources of basic zinc carbonate include: Zinc Carbonate Basic (Cater Chemicals: Bensenville, Ill., USA), Zinc Carbonate (Shepherd Chemicals): Norwood, Ohio, Zinc Carbonate (CPS Union Corp .: New York, NY), Zinc Carbonate (Elementis Pigments: Durham, UK), and Zinc Carbonate AC (Bruggemann Chemical: Newtown Square, Pennsylvania, USA).
塩基性炭酸亜鉛はまた、商業的には「炭酸亜鉛」又は「炭酸亜鉛塩基」又は「ヒドロキシ炭酸亜鉛」と呼ばれる場合もあるが、天然起源の水亜鉛鉱に類似した物質から成る合成の種類である。理想的な化学量論は、Zn5(OH)6(CO3)2で表わされるが実際の化学量論的な比率は、僅かに変化し、他の不純物が、結晶格子内に組み込まれてもよい。 Basic zinc carbonate is also sometimes referred to commercially as “zinc carbonate” or “zinc carbonate base” or “hydroxy zinc carbonate”, but is a synthetic class consisting of materials similar to naturally occurring hydrozincite. is there. The ideal stoichiometry is represented by Zn5 (OH) 6 (CO3) 2, but the actual stoichiometric ratio may vary slightly and other impurities may be incorporated into the crystal lattice. .
c)極性溶媒キャリア
本発明の組成物は、必須成分を提供し、結合剤系に好適なレオロジーを付与するため極性溶媒キャリアを含む。極性溶媒は、水溶性口腔ケア活性物質及びその他の構成成分を組み込むための溶媒としての働きもする。
c) Polar Solvent Carrier The composition of the present invention comprises a polar solvent carrier to provide the essential ingredients and impart suitable rheology to the binder system. The polar solvent also serves as a solvent for incorporating the water soluble oral care active and other components.
極性溶媒は、全組成物の約1重量%〜約95重量%、好ましくは約30重量%〜約70重量%で構成される。 The polar solvent comprises about 1% to about 95%, preferably about 30% to about 70% by weight of the total composition.
本明細書で有用な極性溶媒としては、水、多価アルコール類、例えばグリセリン、1,3−ブチレングリコール、プロピレングリコール、ヘキシレングリコール、プロパンジオール、エチレングリコール、ジエチレングリコール、ジプロピレングリコール、ジグリセリン、ソルビトール、及び周囲温度にて液体形態のその他の糖類が挙げられる。本明細書で有用なものはまた、水溶性アルコキシル化非イオン性ポリマー類、例えばポリエチレングリコールである。 Polar solvents useful herein include water, polyhydric alcohols such as glycerin, 1,3-butylene glycol, propylene glycol, hexylene glycol, propanediol, ethylene glycol, diethylene glycol, dipropylene glycol, diglycerin, Sorbitol and other saccharides in liquid form at ambient temperature. Also useful herein are water soluble alkoxylated nonionic polymers such as polyethylene glycol.
一つの好ましい実施形態において、本組成物は、コスト効果のある製品を提供するため比較的高レベルの水を含むことができる。そのような好ましい実施形態において、水は、全組成物の約30%〜約95%、より好ましくは約50%〜約70%で構成される。 In one preferred embodiment, the composition can include a relatively high level of water to provide a cost effective product. In such preferred embodiments, the water is comprised of about 30% to about 95%, more preferably about 50% to about 70% of the total composition.
本明細書における市販の極性溶媒としては、アサヒデンカ(Asahi Denka)から入手可能なグリセリン;イノレックス(Inolex)から入手可能な商標名レクソル(LEXOL)PG−865/855を有するプロピレングリコール;BASFから入手可能な1,2−プロピレングリコールUSP;ダイセル・カガクコウギョウ(Daisel Kagaku Kogyo)から入手可能な1,3−ブチレングリコール;BASFから入手可能な同じ商標名を有するジプロピレングリコール;ソルベイ社(Solvay GmbH)から入手可能な商標名ジグリセロール(DIGLYCEROL)を有するジグリセリン(diglycerin);ドエケミカル社(Doe Chemical Company)から入手可能な商標名PEG300を有するポリエチレングリコール;及びカリスタ(Khalista)(リウゾウ(Liuzhou))ケミカルインダストリーズ社(Chemical Industries, Ltd.)から入手可能なソルビトール70%溶液が挙げられる。 Commercially available polar solvents herein include glycerin available from Asahi Denka; propylene glycol having the trade name LEXOL PG-865 / 855 available from Inolex; obtained from BASF Possible 1,2-propylene glycol USP; 1,3-butylene glycol available from Daisel Kagaku Kogyo; dipropylene glycol with the same trade name available from BASF; Solvay GmbH Diglycerin with the trade name DIGLYCEROL available from; polyethylene glycol with the trade name PEG300 available from Doe Chemical Company; and Khalista (Liuzhou) Chemical Industries (Ch sorbitol 70% solution available from emical Industries, Ltd.).
研磨材
本発明の組成物は、低レベル又は実質的に全く研磨材を含まず、好ましくは0%〜約10%の研磨材を含む。
Abrasives The compositions of the present invention are low level or substantially free of abrasives, preferably from 0% to about 10% abrasives.
1つの好ましい実施形態において、本組成物は、実質的に研磨材を有しない。すなわち、本発明の組成物は、意図的に含有される研磨材を有しない。驚いたことに、研磨材を有しない本組成物の実施形態は、洗浄、染み除去、歯垢除去、歯石除去及びその他等の典型的に研磨材の使用によるものを含む通常の歯磨剤組成物の利益を提供できることを見出した。研磨材がないことで塩化セチルピリジニウム等の特定の活性物質剤の包含にも順応する、さもないとシリカ等の研磨材との相溶性が悪く、従って、歯磨剤組成物に包含できない。更に、研磨材がないため、歯磨き製品の様々な審美性を追求できる。例えば、透明な外観の組成物を作製できる。 In one preferred embodiment, the composition is substantially free of abrasive. That is, the composition of the present invention does not have an intentionally contained abrasive. Surprisingly, embodiments of the present composition without abrasives are conventional dentifrice compositions including those typically due to the use of abrasives such as cleaning, stain removal, plaque removal, tartar removal and the like. Found that can provide the benefits. The absence of abrasives accommodates the inclusion of certain active agents such as cetylpyridinium chloride, otherwise it is poorly compatible with abrasives such as silica and therefore cannot be included in dentifrice compositions. Furthermore, since there is no abrasive, various aesthetics of toothpaste products can be pursued. For example, a composition having a transparent appearance can be produced.
本組成物で意味する研磨材は、約150mL/100g以下、好ましくは約100mL/100g以下のDOA値及び約5μm〜約50μmの粒径を有する材料として定義される。本明細書における研磨材は、本明細書において結合剤として有用なこれらの材料と区別できる。 An abrasive within the context of the present composition is defined as a material having a DOA value of about 150 mL / 100 g or less, preferably about 100 mL / 100 g or less and a particle size of about 5 μm to about 50 μm. The abrasive herein is distinguishable from those materials useful herein as binders.
本明細書における研磨材としては、シリカゲル類及び沈殿類等の無機ミネラル類;アルミナ類;水和アルミナ;炭酸カルシウム;二酸化チタン:タルク、二酸化カルシウム;炭酸カルシウム;並びに尿素及びホルムアルデヒドの微粒子縮合製品等の樹脂性研磨材が挙げられる。 As abrasives in this specification, inorganic minerals such as silica gels and precipitates; aluminas; hydrated alumina; calcium carbonate; titanium dioxide: talc, calcium dioxide; calcium carbonate; and fine particle condensation products of urea and formaldehyde These resinous abrasives can be mentioned.
フィチン酸化合物
本発明の組成物は、それが歯に有効な洗浄を提供する量でフィチン酸化合物を更に含んでよい。ミオ−イノシトールヘキサホスフェート又はイノシトールヘキサリン酸としても周知のフィチン酸は、EDTAのそれと匹敵できるキレート性能を有する液体形態の天然植物系生分解性キレート剤である。フィチン酸化合物を見つけることができる植物の起原としては、穀物グレイン類、豆果類、木の実脂肪種子類、花粉、胞子及び有機土壌類が挙げられる。
Phytic Acid Compound The composition of the present invention may further comprise a phytic acid compound in an amount that provides effective cleaning for the teeth. Phytic acid, also known as myo-inositol hexaphosphate or inositol hexaphosphoric acid, is a natural form of biodegradable chelating agent in liquid form with chelating performance comparable to that of EDTA. Plant origins from which phytic acid compounds can be found include cereal grains, legumes, nut oil seeds, pollen, spores and organic soils.
本明細書におけるフィチン酸化合物は、アルカリ金属塩類及びアルカリ土類金属塩類を含むがこれらに限定されないフィチン酸自身及び/又はその経口で許容できる塩類であってよい。有用なフィチン酸塩類としては、フィチン酸ナトリウム、フィチン酸カリウム、フィチン酸マグネシウム、フィチン酸カルシウム、フィチン酸スズ、フィチン酸亜鉛、フィチン酸銅、フィチン酸鉄及びこれらの混合物が挙げられる。 The phytic acid compound herein may be phytic acid itself and / or its orally acceptable salts, including but not limited to alkali metal salts and alkaline earth metal salts. Useful phytate salts include sodium phytate, potassium phytate, magnesium phytate, calcium phytate, tin phytate, zinc phytate, copper phytate, iron phytate and mixtures thereof.
驚いたことに、フィチン酸化合物が、本低研磨剤又は研磨剤を有しない組成物において、消費者が気付くほどの染みがない良好な洗浄効果を提供し、本極性溶媒キャリア並びに広範囲の口腔ケア活性物質成分と両立できることを見出した。理論に束縛されないが、フィチン酸化合物は、歯の間を流れることによりその液体形態のため特有の良好な洗浄を提供すると思われる。そのような流れが、ある意味では固体研磨材と異なる洗浄を提供すると思われる。更に、フィチン酸化合物は、歯エナメル質を酸溶解から保護する明白な効果及び抗歯石効果を提供すると思われる。 Surprisingly, the phytic acid compound provides a good cleansing effect that is not noticeable to consumers in compositions that do not have this low abrasive or abrasive, and this polar solvent carrier as well as a wide range of oral care It has been found that it is compatible with the active substance component. Without being bound by theory, it appears that phytic acid compounds provide unique good cleansing due to their liquid form by flowing between the teeth. Such a flow would provide cleaning in a sense different from a solid abrasive. Furthermore, phytic acid compounds appear to provide a clear and anticalculus effect that protects tooth enamel from acid dissolution.
本明細書で有用な市販のフィチン酸化合物としては、シチュアン・チェング・ヤソン(Sichuan Chengdu Yason)、シキシマ・スターチ・マニュファクチャリング社(Shikishima Starch Manufacturing Company)及びニビオ(Nibbio)から入手可能なフィチン酸溶液、フィチン酸ナトリウム、フィチン酸マグネシウム、フィチン酸カルシウム及びフィチン酸スズが挙げられる。 Commercially available phytic acid compounds useful herein include phytic acid available from Sichuan Chengdu Yason, Shikishima Starch Manufacturing Company and Nibbio. Examples include solutions, sodium phytate, magnesium phytate, calcium phytate, and tin phytate.
追加の構成成分
本発明の組成物は他の追加的な構成成分を含んでもよく、それは最終的な製品の所望の特性によって当業者により選択されてもよく、それは組成物をより美容的又は審美的に許容可能なものにしたり、付加的な使用による利益を組成物に提供するのに好適なものである。こうした追加構成成分は、一般に組成物の約5重量%以下の濃度でそれぞれ使用される。
Additional Components The composition of the present invention may contain other additional components, which may be selected by those skilled in the art depending on the desired properties of the final product, which makes the composition more cosmetic or aesthetic. It is suitable for making the composition acceptable and providing the benefits of additional use to the composition. These additional components are each typically used at a concentration of about 5% or less by weight of the composition.
界面活性剤類は、口腔に適用されたときに口腔全体にわたって歯磨剤の十分な分散を助け、並びに化粧品の受容性及び発泡性を改善するための成分として本発明の構成成分に組み込まれてよい。本組成物に包含できる界面活性剤類としては、アニオン性、非イオン性又は両性化合物が挙げられ、アニオン性化合物が好ましい。 Surfactants may be incorporated into the components of the present invention as ingredients to help adequate dispersion of the dentifrice throughout the oral cavity and improve cosmetic acceptability and foamability when applied to the oral cavity. . Surfactants that can be included in the composition include anionic, nonionic or amphoteric compounds, with anionic compounds being preferred.
アニオン性界面活性剤類の好適な例は、ラウリル硫酸カリウム又はラウリル硫酸ナトリウム等の高級アルキルサルフェート類、そしてそれが好ましい、水素添加ココヤシ油脂肪酸類のモノ硫酸化モノグリセリドの塩類等の高級脂肪酸モノグリセリドモノスルフェート類、ドデシルベンゼンスルホン酸ナトリウム等のアルキルスルホネート類、高級脂肪スルホアセテート類、1,2ジヒドロキシプロパンスルホネートの高級脂肪酸エステル類である。 Suitable examples of anionic surfactants include higher alkyl sulfates such as potassium lauryl sulfate or sodium lauryl sulfate, and higher fatty acid monoglyceride monohydrates such as salts of monosulfated monoglycerides of hydrogenated coconut oil fatty acids, which are preferred Sulfates, alkyl sulfonates such as sodium dodecylbenzenesulfonate, higher fat sulfoacetates, and higher fatty acid esters of 1,2 dihydroxypropane sulfonate.
両性界面活性剤類の例は、ゴールドシュミット・ケミカル社(Goldschmidt Chemical Corp.)からの商品名テゴ・ベタイン(TEGO Betaine)ZFを有するコカミドプロピルベタイン等のアルキル化ベタイン製品である。 Examples of amphoteric surfactants are alkylated betaine products such as cocamidopropyl betaine with the trade name TEGO Betaine ZF from Goldschmidt Chemical Corp.
水溶性非イオン性界面活性剤類の例は、それと反応しやすく疎水性長鎖(例えば、約12〜20個の炭素原子の脂肪族鎖)を有する種々の水素含有化合物類を有するエチレンオキシドの縮合生成物、例えばプルロニック(Pluronic)F127等のプルロニック(Pluronic)物質であって、その縮合生成物は、脂肪酸類、脂肪族アルコール類、脂肪酸アミド類及びその他の脂肪酸部分並びにプロピレンオキシド及びポリプロピレンオキシド類を有するポリ(エチレンオキシド)の縮合生成物等の親水性ポリオキシエチレン部分を含有する。 Examples of water-soluble nonionic surfactants are condensation of ethylene oxide with various hydrogen-containing compounds that are easy to react with it and have a long hydrophobic chain (eg, an aliphatic chain of about 12-20 carbon atoms). Products, such as Pluronic materials such as Pluronic F127, which condensation products contain fatty acids, fatty alcohols, fatty acid amides and other fatty acid moieties and propylene oxide and polypropylene oxides. It contains a hydrophilic polyoxyethylene moiety such as a poly (ethylene oxide) condensation product.
界面活性剤は、本組成物中に約0.5〜約10.0重量%、好ましくは約1〜約2重量%の濃度で存在できる。 The surfactant can be present in the composition at a concentration of about 0.5 to about 10.0% by weight, preferably about 1 to about 2% by weight.
本発明の歯磨剤構成成分に組み込まれてよいその他の成分としては、顔料類、染料類、香味材類及び甘味材類が挙げられる。例えば、ストリップ製品は、本発明により得られ、そこでは対照的な色の着色剤が本発明の実行で使用される構成成分の各々に組み込まれる、ここで着色剤は、提案された量で使用したとき薬理学的及び生理学的に無害である。本発明に使用される着色剤としては、顔料及び染料の両方が挙げられる。 Other ingredients that may be incorporated into the dentifrice constituents of the present invention include pigments, dyes, flavors and sweeteners. For example, strip products are obtained according to the invention, in which a contrasting colorant is incorporated into each of the components used in the practice of the invention, where the colorant is used in the proposed amount. It is harmless pharmacologically and physiologically. Colorants used in the present invention include both pigments and dyes.
本発明に有用な顔料としては、無害の二酸化チタン及び酸化クロムグリーン、ウルトラマリンブルー及びピンク、三酸化ニ鉄等の非水溶性無機顔料類、並びにFD&Cグリーン#1レーキ、FD&Cブルー#2レーキ、FD&C R&D#30レーキ、FD&C#5イエロー及びFD&Cイエロー#15レーキ等のFD&C染料のカルシウム又はアルミニウム塩をアルミニウム上に延ばすことにより調製される非水溶性染料レーキ類が挙げられる。本組成物中の染料の濃度は、約3重量%以下である。本明細書における顔料類は、研磨材と区別され、本明細書の顔料類は、100〜約1,000μ、好ましくは約250〜約500μの範囲の粒径を有するので本組成物は、実質的に研磨材がない。存在する場合、顔料類は、約0.5重量%〜約3重量%で本組成物中に含まれる。 Useful pigments for the present invention include harmless titanium dioxide and chromium oxide green, ultramarine blue and pink, water-insoluble inorganic pigments such as ferric trioxide, FD & C green # 1 lake, FD & C blue # 2 lake, Water-insoluble dye lakes prepared by extending calcium or aluminum salts of FD & C dyes such as FD & C R & D # 30 lake, FD & C # 5 yellow and FD & C yellow # 15 lake onto aluminum. The concentration of the dye in the composition is about 3% by weight or less. The pigments herein are distinguished from abrasives and the pigments herein have a particle size in the range of 100 to about 1,000 microns, preferably about 250 to about 500 microns, so that the composition is substantially There is no abrasive material. When present, pigments are included in the composition at about 0.5 wt% to about 3 wt%.
任意の好適な香味材又は甘味材が、本発明の構成成分中に組み込まれてよい。好適な香味料構成要素の例は、香味油、例えばスペアミント、ペパーミント、冬緑油、サッサフラス、クローブ、セージ、ユーカリ、マジョラム、桂皮の油、レモン、オレンジ及びサリチル酸メチルである。好適な甘味剤としては、スクロース、ラクトース、マルトース、ソルビトール、キシリトール、シクラミン酸ナトリウム、ペリラチン(perillartine)及びサッカリンナトリウムが挙げられる。香味及び甘味剤類は、共に好適に調剤品の0.01重量%〜5重量%又はそれ以上を含んでよい。 Any suitable flavoring or sweetening material may be incorporated into the components of the present invention. Examples of suitable flavor components are flavor oils such as spearmint, peppermint, winter green oil, sassafras, cloves, sage, eucalyptus, marjoram, cinnamon oil, lemon, orange and methyl salicylate. Suitable sweetening agents include sucrose, lactose, maltose, sorbitol, xylitol, sodium cyclamate, perillartine and sodium saccharin. Both flavor and sweeteners may suitably comprise from 0.01% to 5% by weight or more of the preparation.
リン酸一ナトリウム及びリン酸三ナトリウム、酵素阻害剤、植物抽出物類、天然ハーブ抽出物類及びその他等の緩衝剤類が含まれてよい。 Buffering agents such as monosodium phosphate and trisodium phosphate, enzyme inhibitors, plant extracts, natural herbal extracts and others may be included.
下記の歯磨剤組成物は、本明細書に記載した調製方法を使用した以下の構成成分により形成される。
構成成分の定義
*1 フッ化ナトリウム:NaF、ジナン・ケミカル・インダストリー社(Jinan Chemical Industry Co. Ltd)から入手可能.
*2 ソルビトール(70%溶液):ソルビトール70%溶液、カリスタ(Khalista)(リウゾウ(Liuzhou))ケミカルインダストリーズ社(Chemical Industries, Ltd.)から入手可能
*3 グリセリン99.5%:グリセリンアサヒデンカから入手可能
*4 ポリエチレングリコール:PEG−300、ドエケミカル社(Doe Chemical Company)から入手可能
*5 ラウリル硫酸ナトリウム(28%溶液):SLSS、ローディア・スペシャルテイ・ケミカル・ウキシ社(Rhodia Specialty Chemical Wuxi Co. Ltd.)から入手可能
*6 カルボキシメチルセルロースナトリウム:CMC、ザングジアガング市(Zhangjiagang city)サンフイ・ケミカル・インダストリー社(Sanhui Chemical Industry Co.,Ltd)から入手可能
*7 ヒドロキシエチルセルロース:ナトロソール(NATROSOL)ハーキュレスから入手可能
*8 カーボポール:カルボマー956、ノベオン社(Noveon, Inc)から入手可能
*9 キサンタンガム:ケルデント(KELDENT)、CPケルコ社(CP Kelco Inc.)から入手可能
*10 ジェランガム−CPケルコ社(CP Kelco Inc.)から商品名ケルコゲル(KELCOGEL)シリーズにより
*11 カラギーナン:ゲルカリン(GELCARIN)TP911 FMC社(FMC Corporation)食品成分部門から入手可能
*12 合成層状ケイ酸マグネシウム 0.2%フッ化物:ラポナイトDF、ロックウッド・アディティブ社(Rockwood Additives Limited)から入手可能
*13 合成層状ケイ酸マグネシウム:ラポナイトD、ロックウッド・アディティブ社(Rockwood Additives Limited)から入手可能
*14 非晶質沈殿シリカ:ゼオデント(Zeodent)165、J.M.フーバ社(Huber Company)から入手可能
*15 ヒュームドシリカ:エアゾール、カボット&デグッサ社(Cabot & Degussa Corporation)から入手可能
*16 沈殿シリカ−研磨剤:ゼオデント(Zeodent)119及びゼオデント(Zeodent)109 J.M.フーバ社(Huber Company)から入手可能
*17 雲母、二酸化チタンコーティング:ロナ(Rona)から入手可能
*18 水酸化ナトリウム溶液(50%):NaOH50%、グアンゾウ・ケミカル社(Guangzhou Chemical Company)から入手可能
*19 ピロリン酸四ナトリウム:ピロリン酸ナトリウム、テトラ(無水の)、リアンユンガング・デオリング・ファイン・ケミカル社(Lianyungang Duoling Fine Chemical Co. Ltd.)から入手可能
*20 リン酸ナトリウム、一塩基性、一水和物:MSP、ジアングス・ケングキシング・ホスフェート・ケミカル社(Jiangsu Chengxing Phosphate Chemical Co. Ltd)から入手可能
*21 三塩基性リン酸ナトリウム:TSP、ジアングス・ジアンギンホスホ・ケミカルズ(Jiangsu Jiangyin Phosph Chemicals)から入手可能
*22 フィチン酸ナトリウム20%溶液:シチュアン・チェング・ヤソン(Sichuan Chengdu Yason)から入手可能
*23 サッカリンナトリウム:スゾウ・ファイン・ケミカル(Suzhou Fine Chemical)から入手可能
*24 フッ化第一スズ:SnF2、ハシモト(Hashimoto)から入手可能
*25 コカミドプロピルベタイン30%溶液:テゴ・ベタイン(TEGO Betaine)ZFゴールドシュミット・ケミカル社(Goldschmidt Chemical Corp.)から入手可能
*26 トリクロサン:チバ−ガイギーケミカルズ社(Ciba-Geigy Chemicals Ltd.)から入手可能
*27 塩化セチルピリジニウム:カンブレックス社(Cambrex company)から入手可能
*28 炭酸亜鉛:ブラグマンケミカル(Bruggemann Chemical)から入手可能
*29 ジメチルイソソルビド:アラソルブ(Arlasolve)DMIユニケマ(Uniqema)から入手可能
Definition of components
* 1 Sodium fluoride: NaF, available from Jinan Chemical Industry Co. Ltd.
* 2 Sorbitol (70% solution): 70% sorbitol solution, available from Khalista (Liuzhou) Chemical Industries, Ltd.
* 3 Glycerin 99.5%: Available from Glycerin Asahidenka
* 4 Polyethylene glycol: PEG-300, available from Doe Chemical Company
* 5 Sodium lauryl sulfate (28% solution): SLSS, available from Rhodia Specialty Chemical Wuxi Co. Ltd.
* 6 Sodium carboxymethyl cellulose: CMC, available from Sanhui Chemical Industry Co., Ltd., Zhangjiagang city
* 7 Hydroxyethyl cellulose: available from NATROSOL Hercules
* 8 Carbopol: Carbomer 956, available from Noveon, Inc.
* 9 Xanthan gum: available from KELDENT, CP Kelco Inc.
* 10 From the gellan gum-CP Kelco Inc. under the trade name KELCOGEL series
* 11 Carrageenan: GELCALIN TP911 Available from FMC Corporation's Food Ingredients Division
* 12 Synthetic layered magnesium silicate 0.2% fluoride: Laponite DF, available from Rockwood Additives Limited
* 13 Synthetic layered magnesium silicate: Laponite D, available from Rockwood Additives Limited
* 14 Amorphous precipitated silica: Zeodent 165; M.M. Available from Huber Company
* 15 Fumed silica: available from Aerosol, Cabot & Degussa Corporation
* 16 Precipitated silica-abrasive: Zeodent 119 and Zeodent 109 M.M. Available from Huber Company
* 17 Mica, titanium dioxide coating: available from Rona
* 18 Sodium hydroxide solution (50%): NaOH 50%, available from Guangzhou Chemical Company
* 19 Tetrasodium pyrophosphate: Sodium pyrophosphate, tetra (anhydrous), available from Lianyungang Duoling Fine Chemical Co. Ltd.
* 20 Sodium phosphate, monobasic, monohydrate: MSP, available from Jiangsu Chengxing Phosphate Chemical Co. Ltd
* 21 Tribasic sodium phosphate: TSP, available from Jiangsu Jiangyin Phosph Chemicals
* 22 Sodium phytate 20% solution: available from Sichuan Chengdu Yason
* 23 Saccharin sodium: available from Suzhou Fine Chemical
* 24 Stannous fluoride: SnF2, available from Hashimoto
* 25 Cocamidopropyl betaine 30% solution: available from TEGO Betaine ZF Goldschmidt Chemical Corp.
* 26 Triclosan: available from Ciba-Geigy Chemicals Ltd.
* 27 Cetylpyridinium chloride: available from Cambrex company
* 28 Zinc carbonate: available from Bruggemann Chemical
* 29 Dimethylisosorbide: available from Arlasolve DMI Uniqema
調製方法
実施例1〜10の歯磨剤組成物は、当業者に周知の任意の方法で作製でき、好適には以下のように調製される。
Preparation Method The dentifrice compositions of Examples 1 to 10 can be prepared by any method known to those skilled in the art, and are preferably prepared as follows.
先ず、親水性粘土材(構成成分番号12〜14)を室温で容器内の水の部分に分散し、プロペラミキサー(Propeller Mixer)を使用して均質になるまで混合する。別の主要ミックスポット中で、ソルビトール(構成成分番号2)、グリセリン(構成成分番号3)、ポリエチレングリコール(構成成分番号4)、水酸化ナトリウム溶液(構成成分番号18)、組成物中に存在するとき染料及び顔料(構成成分番号17)並びに水の残りの部分を組成物と一緒に混合し、高温、2.6ラジアン/秒(25rpm)〜3.7ラジアン/秒(35rpm)の回転速度で攪拌機で一緒に混合する。 First, a hydrophilic clay material (component Nos. 12 to 14) is dispersed in a portion of water in a container at room temperature, and mixed using a propeller mixer (Propeller Mixer) until homogeneous. In another major mix spot, sorbitol (component number 2), glycerin (component number 3), polyethylene glycol (component number 4), sodium hydroxide solution (component number 18), present in the composition Sometimes the dyes and pigments (component number 17) and the rest of the water are mixed together with the composition and at a high temperature and a rotational speed of 2.6 radians / second (25 rpm) to 3.7 radians / second (35 rpm) Mix together with a stirrer.
香味料及び界面活性剤(構成成分番号5及び25)を除いた全ての残りの構成成分を主要ミックスポットに添加する。ポットを気密にして閉じ、約13.3kPa(100mmHg)の真空を形成し、ホモジナイザーを251.3ラジアン/秒(2400rpm)〜366.5ラジアン/秒(3500rpm)の回転速度で回転する。得られた混合物を更に脱気する。 Add all remaining components except the flavor and surfactant (component numbers 5 and 25) to the main mix spot. The pot is hermetically closed, a vacuum of about 13.3 kPa (100 mmHg) is created, and the homogenizer is rotated at a rotational speed of 251.3 radians / second (2400 rpm) to 366.5 radians / second (3500 rpm). The resulting mixture is further degassed.
第1工程で作製した混合物をこれに加える。得られた混合物を混合し、脱気する。最後に香味料及び界面活性剤(構成成分番号5及び25)を添加し、ポットを再度気密にして閉じ、最終的に均質化するため2251.3ラジアン/秒(2400rpm)〜366.5ラジアン/秒(3500rpm)の回転速度で回転するホモジナイザーで混合し、脱気する。 To this is added the mixture made in the first step. The resulting mixture is mixed and degassed. Finally, flavors and surfactants (component numbers 5 and 25) are added and the pot is again airtight and closed to finally homogenize from 2251.3 radians / second (2400 rpm) to 366.5 radians / Mix with a homogenizer rotating at a rotation speed of 2 seconds (3500 rpm) and degas.
得られた生成物を容器からポンプで取り出し、ラミネートチューブ等の一次包装に引き渡す。 The resulting product is pumped out of the container and delivered to the primary packaging such as a laminate tube.
本明細書の実施例の組成物は、歯磨剤製品向けに好適な多くの利益を有する。全ての組成物は、10,000〜45,000Paの粘度を有し、10%を超える研磨材を含有する練り歯磨きと比べて歯表面により少ない磨耗を提供し、歯エナメル質に対してより安全である。全ての組成物は、研磨材を含む練り歯磨きと比べて柔らかい口感触、より容易な分散、歯間部分への改善された進入を提供する。全ての組成物は、研磨材及び同じ香味料の同じレベル含む練り歯磨きと比べてよりよく消費者が香味を知覚できる。更に、全ての組成物は、経済的なコストで製造できる。実施例1〜2の組成物は、抗カリエス、抗歯垢、白化、抗結石及び抗歯肉炎効果を提供する。実施例3〜5、7及び10の組成物は、抗カリエス、抗歯垢、白化、及び抗結石効果を提供する。実施例6の組成物は、抗カリエス、抗歯垢及び白化効果を提供する。実施例8〜9の組成物は、抗カリエス、抗歯垢、白化、抗結石及び抗菌効果を提供する。 The example compositions herein have many benefits that are suitable for dentifrice products. All compositions have a viscosity of 10,000-45,000 Pa and provide less wear on the tooth surface compared to toothpaste containing more than 10% abrasive and safer for tooth enamel It is. All compositions provide a soft mouth feel, easier dispersion, and improved penetration into the interdental area compared to toothpastes containing abrasives. All compositions are better perceivable by consumers compared to toothpastes containing the same level of abrasive and the same flavoring. Furthermore, all compositions can be manufactured at an economical cost. The compositions of Examples 1-2 provide anti-caries, anti-plaque, whitening, anti-calculus and anti-gingivitis effects. The compositions of Examples 3-5, 7, and 10 provide anti-caries, anti-plaque, whitening, and anti-calculus effects. The composition of Example 6 provides anti-caries, anti-plaque and whitening effects. The compositions of Examples 8-9 provide anti-caries, anti-plaque, whitening, anti-calculus and antibacterial effects.
本明細書に開示される寸法及び値は、列挙された正確な数値に厳しく制限されるものとして理解されるべきでない。それよりむしろ、特に指定されない限り、各こうした寸法は、列挙された値とその値周辺の機能的に同等の範囲の両方を意味することを意図する。例えば、「40mm」として開示された寸法は、「約40mm」を意味することを意図する。 The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm”.
「発明を実施するための最良の形態」で引用したすべての文献は、関連部分において本明細書に参考として組み込まれているが、いずれの文献の引用も、本発明に対する先行技術であることの容認と解釈されるべきではない。この文書における用語のいずれかの意味または定義が、参考として組み込まれる文献における用語のいずれかの意味または定義と対立する範囲については、本文書におけるその用語に与えられた意味または定義を適用するものとする。 All documents cited in “Best Mode for Carrying Out the Invention” are incorporated herein by reference in the relevant part, but any citation of any document is prior art to the present invention. It should not be interpreted as acceptance. To the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of a term in a document incorporated by reference, the meaning or definition given to that term in this document applies And
本発明の特定の実施形態を例示し説明してきたが、本発明の精神及び範囲から逸脱することなく、他の様々な変更及び修正を実施できることが当業者には明白であろう。したがって、本発明の範囲内にあるそのような全ての変更および修正を、添付の特許請求の範囲で扱うものとする。 While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
Claims (14)
i)親水性粘土材;
ii)変性セルロースポリマー;
iii)カルボキシビニルポリマー;及び
iv)天然ゴム由来アニオン性ポリマー類
を含む約10,000Pa〜約450,000Paの粘度を有する結合剤系;
(b)有効量の口腔ケア活性物質;並びに
(c)極性溶媒キャリア
を含む、歯磨剤組成物。 (A)
i) hydrophilic clay material;
ii) modified cellulose polymers;
iii) a carboxyvinyl polymer; and iv) a binder system having a viscosity of about 10,000 Pa to about 450,000 Pa, comprising natural rubber-derived anionic polymers;
(B) an effective amount of an oral care active; and (c) a dentifrice composition comprising a polar solvent carrier.
i)約0.01%〜約5%の前記親水性粘土材;
ii)約0.01%〜約5%の前記変性セルロースポリマー;
iii)約0.01%〜約5%の前記カルボキシビニルポリマー;および
iv)約0.01%〜約5%の前記天然ゴム由来アニオン性ポリマー類
を含む、請求項1に記載の歯磨剤組成物。 About 0.1% to about 10% of the binder system, the binder system comprising:
i) about 0.01% to about 5% of said hydrophilic clay material;
ii) about 0.01% to about 5% of the modified cellulose polymer;
The dentifrice composition of claim 1, comprising iii) about 0.01% to about 5% of said carboxyvinyl polymer; and iv) about 0.01% to about 5% of said natural rubber-derived anionic polymers. object.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74053805P | 2005-11-29 | 2005-11-29 | |
US75140405P | 2005-12-16 | 2005-12-16 | |
US11/545,266 US20070122357A1 (en) | 2005-11-29 | 2006-10-10 | Dentifrice composition |
PCT/IB2006/054511 WO2007063507A2 (en) | 2005-11-29 | 2006-11-29 | Dentifrice composition comprising binder system comprising hydrophilic clay material |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2009519235A true JP2009519235A (en) | 2009-05-14 |
Family
ID=38016398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008542918A Withdrawn JP2009519235A (en) | 2005-11-29 | 2006-11-29 | Dentifrice composition comprising a binder system comprising a hydrophilic clay material |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1954239A2 (en) |
JP (1) | JP2009519235A (en) |
KR (1) | KR20080072876A (en) |
AU (1) | AU2006321207A1 (en) |
BR (1) | BRPI0619389A2 (en) |
CA (1) | CA2631254A1 (en) |
WO (1) | WO2007063507A2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012056868A (en) * | 2010-09-08 | 2012-03-22 | Lion Corp | Dentifrice composition |
JP2012116772A (en) * | 2010-11-30 | 2012-06-21 | Lion Corp | Dentifrice composition |
JP2012149035A (en) * | 2010-12-27 | 2012-08-09 | Lion Corp | Tooth powder composition |
JP2014037444A (en) * | 2013-11-28 | 2014-02-27 | Lion Corp | Dentifrice composition |
JP2014125425A (en) * | 2012-12-25 | 2014-07-07 | Kao Corp | Liquid oral composition |
JP2014139182A (en) * | 2006-02-17 | 2014-07-31 | Universitat De Les Illes Balears | Fixed-dose association of phytate and zinc |
JP2019196367A (en) * | 2013-10-08 | 2019-11-14 | イノファーマ インク | Oral liquid aprepitant formulations |
JP2022058996A (en) * | 2017-05-31 | 2022-04-12 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Pumping type toothpaste composition |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5097841B2 (en) | 2011-04-08 | 2012-12-12 | 花王株式会社 | Oral composition |
US9308158B2 (en) | 2011-07-12 | 2016-04-12 | Conopco, Inc. | Toothpaste comprising calcium based abrasives |
ES2617492T3 (en) | 2012-12-19 | 2017-06-19 | Colgate-Palmolive Company | Antiperspirant products with protein and antiperspirant salts |
CN104853725B (en) | 2012-12-19 | 2018-07-20 | 高露洁-棕榄公司 | Include the oral care composition of zinc and amino-acids halide |
MX353167B (en) | 2012-12-19 | 2017-12-20 | Colgate Palmolive Co | Teeth whitening methods, visually perceptible signals and compositions therefor|comprising zinc amino acid halides. |
RU2638791C2 (en) | 2012-12-19 | 2017-12-15 | Колгейт-Палмолив Компани | Composition with halide precursors of amino acid / zinc trimethylglycine |
EP2934444B1 (en) | 2012-12-19 | 2016-11-30 | Colgate-Palmolive Company | Oral care products comprising tetrabasic zinc chloride and trimethylglycine |
AU2012397265B2 (en) | 2012-12-19 | 2016-02-25 | Colgate-Palmolive Company | Oral gel comprising zinc - amino acid complex |
CA2892175C (en) | 2012-12-19 | 2019-10-15 | Colgate-Palmolive Company | Zinc amino acid/trimethylglycine halide |
US9675823B2 (en) | 2012-12-19 | 2017-06-13 | Colgate-Palmolive Company | Two component compositions containing zinc amino acid halide complexes and cysteine |
US9901523B2 (en) | 2012-12-19 | 2018-02-27 | Colgate-Palmolive Company | Oral care products comprising zinc oxide and trimethylglycine |
US9504858B2 (en) | 2012-12-19 | 2016-11-29 | Colgate-Palmolive Company | Zinc amino acid halide complex with cysteine |
US9498421B2 (en) | 2012-12-19 | 2016-11-22 | Colgate-Palmolive Company | Two component compositions containing tetrabasic zinc-amino acid halide complexes and cysteine |
KR20150097551A (en) | 2012-12-19 | 2015-08-26 | 콜게이트-파아므올리브캄파니 | Zinc amino acid halide mouthwashes |
CN104884033B (en) * | 2012-12-19 | 2018-04-20 | 高露洁-棕榄公司 | Zinc amino acid chelate and cysteine |
BR112015014445A2 (en) | 2012-12-19 | 2017-07-11 | Colgate Palmolive Co | zinc-lysine complex |
RU2625763C2 (en) * | 2012-12-19 | 2017-07-18 | Колгейт-Палмолив Компани | Products for oral care containing tetrabasic zinc amino acid halogenide complex |
US9750670B2 (en) | 2012-12-19 | 2017-09-05 | Colgate-Palmolive Company | Zinc amino acid complex with cysteine |
US10188112B2 (en) | 2012-12-19 | 2019-01-29 | Colgate-Palmolive Company | Personal cleansing compositions containing zinc amino acid/trimethylglycine halide |
AU2013408427B2 (en) | 2013-12-16 | 2017-02-02 | Colgate-Palmolive Company | Oral care compositions comprising calcium carbonate and a clay |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0784373B2 (en) * | 1986-12-26 | 1995-09-13 | ライオン株式会社 | Oral composition |
GB0016067D0 (en) * | 2000-06-30 | 2000-08-23 | Procter & Gamble | Oral compositions |
US20030131536A1 (en) * | 2001-12-21 | 2003-07-17 | Kostinko John A. | Precipitated silica |
US8491877B2 (en) * | 2003-03-18 | 2013-07-23 | The Procter & Gamble Company | Composition comprising zinc-containing layered material with a high relative zinc lability |
-
2006
- 2006-11-29 AU AU2006321207A patent/AU2006321207A1/en not_active Abandoned
- 2006-11-29 BR BRPI0619389-7A patent/BRPI0619389A2/en not_active Application Discontinuation
- 2006-11-29 JP JP2008542918A patent/JP2009519235A/en not_active Withdrawn
- 2006-11-29 WO PCT/IB2006/054511 patent/WO2007063507A2/en active Application Filing
- 2006-11-29 KR KR1020087012827A patent/KR20080072876A/en not_active Application Discontinuation
- 2006-11-29 EP EP06832006A patent/EP1954239A2/en not_active Withdrawn
- 2006-11-29 CA CA002631254A patent/CA2631254A1/en not_active Abandoned
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014139182A (en) * | 2006-02-17 | 2014-07-31 | Universitat De Les Illes Balears | Fixed-dose association of phytate and zinc |
JP2012056868A (en) * | 2010-09-08 | 2012-03-22 | Lion Corp | Dentifrice composition |
JP2012116772A (en) * | 2010-11-30 | 2012-06-21 | Lion Corp | Dentifrice composition |
JP2012149035A (en) * | 2010-12-27 | 2012-08-09 | Lion Corp | Tooth powder composition |
JP2014125425A (en) * | 2012-12-25 | 2014-07-07 | Kao Corp | Liquid oral composition |
JP2019196367A (en) * | 2013-10-08 | 2019-11-14 | イノファーマ インク | Oral liquid aprepitant formulations |
JP2021169504A (en) * | 2013-10-08 | 2021-10-28 | イノファーマ インク | Aprepitant oral liquid formulations |
JP2014037444A (en) * | 2013-11-28 | 2014-02-27 | Lion Corp | Dentifrice composition |
JP2022058996A (en) * | 2017-05-31 | 2022-04-12 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Pumping type toothpaste composition |
JP7317433B2 (en) | 2017-05-31 | 2023-07-31 | エルジー ハウスホールド アンド ヘルスケア リミテッド | Pump type dentifrice composition |
US11771642B2 (en) | 2017-05-31 | 2023-10-03 | Lg Household & Health Care Ltd. | Pumping type toothpaste composition |
Also Published As
Publication number | Publication date |
---|---|
AU2006321207A1 (en) | 2007-06-07 |
WO2007063507A2 (en) | 2007-06-07 |
CA2631254A1 (en) | 2007-06-07 |
EP1954239A2 (en) | 2008-08-13 |
WO2007063507A3 (en) | 2007-10-11 |
BRPI0619389A2 (en) | 2011-10-04 |
KR20080072876A (en) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009519235A (en) | Dentifrice composition comprising a binder system comprising a hydrophilic clay material | |
JP2009513695A (en) | Dentifrice composition without abrasives | |
US20070122359A1 (en) | Dentifrice composition comprising binder system comprising hydrophilic clay material | |
CN100548265C (en) | Oral care kits and compositions | |
JP3945703B2 (en) | System for delivering cosmetic and / or therapeutically active substances to the oral surface using an integrated carrier | |
CN105120960B (en) | Include the oral care composition of organic poly sesquisiloxane particle | |
US20070122358A1 (en) | Dentifrice composition free of abrasive material | |
ES2543613T3 (en) | Films and compositions comprising the same | |
JP4055849B2 (en) | Dental treatment composition | |
TWI449538B (en) | Oral care product and methods of use and manufacture thereof | |
TW201521771A (en) | Tooth whitening oral care product | |
CN104853810A (en) | Stable metal ion containing compositions | |
AU2013408274A1 (en) | Anti-malodor oral care composition | |
CN101316571A (en) | Dentifrice composition free of abrasive material | |
CN104853736A (en) | Oral care composition containing ionic liquids | |
MX2008006887A (en) | Dentifrice composition free of abrasive material | |
RU2722646C1 (en) | Oral care composition with improved appearance and shape | |
KR20060060291A (en) | Toothpaste composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20090703 |